<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Psm-8) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">60</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 10884,
    "choices": [
      {
        "id": 43502,
        "text": "<p><span style=\"font-size:12.0pt;\">With more than 1 incubation period</span></p>"
      },
      {
        "id": 43503,
        "text": "<p><span style=\"font-size:12.0pt;\">Explosive in nature</span></p>"
      },
      {
        "id": 43504,
        "text": "<p><span style=\"font-size:12.0pt;\">With multiple peaks</span></p>"
      },
      {
        "id": 43505,
        "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a small coastal town in Kerala, a sudden surge of gastroenteritis cases is reported within two days after a community seafood feast. Health officials suspect the seafood feast as the source of the epidemic. Which of the following statements is true regarding this type of single exposure point source epidemic? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q1316138",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175430,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Explosive in nature</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Single exposure or \u2018Point source\u2019 epidemics characteristics:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">\u2018Sharp rise and sharp fall\u2019 in no. of cases i.e., single wave&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">\u2018Clustering of cases\u2019 in a narrow interval of time</span></li><li><span style=\"font-size:12.0pt;\">All \u2018cases develop within one incubation period\u2019 of the disease.</span></li><li><span style=\"font-size:12.0pt;\">Examples: Food poisoning, Measles, Chicken pox, Cholera, BHOPAL GAS TRAGEDY</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-113315.jpg\" alt=\"\" width=\"700\" height=\"492\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. With more than 1 incubation period:</strong> Incorrect as single exposure epidemics are confined to one incubation period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. With multiple peaks:</strong> Incorrect as single exposure epidemics typically have a single peak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Single exposure point source epidemics are explosive in nature with a rapid increase and decline in cases, confined to one incubation period.</span></p>",
    "correct_choice_id": 43503,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 46439,
    "choices": [
      {
        "id": 185375,
        "text": "<p><span style=\"font-size:12.0pt;\">Anemia Mukt Bharat program</span></p>"
      },
      {
        "id": 185376,
        "text": "<p><span style=\"font-size:12.0pt;\">Ayushman Bharat program</span></p>"
      },
      {
        "id": 185377,
        "text": "<p><span style=\"font-size:12.0pt;\">Swachh Bharat Mission</span></p>"
      },
      {
        "id": 185378,
        "text": "<p><span style=\"font-size:12.0pt;\">Poshan Abhiyan</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Under which health program, the School Health was combined in the year 2018? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q2121156",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175465,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ayushman Bharat program</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In 2018, the School Health program was integrated under the Ayushman Bharat program. This integration involved the <strong>Ministry of Health and Family Welfare and the Ministry of Human Resource Development. </strong>Here, School teachers to be made the<strong> Health &amp; Wellness ambassadors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The program focuses on various health initiatives for school children are \u2013</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Iron and folic acid supplementation,</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Deworming with albendazole tablets</strong>,</span></li><li><span style=\"font-size:12.0pt;\">Distribution of <strong>sanitary napkins</strong> to adolescent girls,</span></li><li><span style=\"font-size:12.0pt;\"><strong>Age-appropriate vaccination,</strong></span></li><li><span style=\"font-size:12.0pt;\">Maintenance of <strong>electronic health records</strong>, and</span></li><li><span style=\"font-size:12.0pt;\"><strong>Teaching first aid</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Additionally, the program is part of the <strong>Rashtriya Bal Swasthya Karikram (RBSK</strong>), targeting the screening of <strong>30 disorders</strong> in children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anemia Mukt Bharat program</strong>: This program aims to reduce anemia across the population, particularly among women and children, but it is not the program under which the School Health program was integrated in 2018.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Swachh Bharat Mission</strong>: This initiative focuses on cleanliness and sanitation across India but is not related to the School Health program integration.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Poshan Abhiyan</strong>: This mission targets improving nutritional outcomes for children, pregnant women, and lactating mothers but does not encompass the School Health program's integration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In 2018, the School Health program was integrated into the Ayushman Bharat program, involving health and wellness initiatives for school children.</span></p>",
    "correct_choice_id": 185376,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10878,
    "choices": [
      {
        "id": 43478,
        "text": "<p><span style=\"font-size:12.0pt;\">100</span></p>"
      },
      {
        "id": 43479,
        "text": "<p><span style=\"font-size:12.0pt;\">1000</span></p>"
      },
      {
        "id": 43480,
        "text": "<p><span style=\"font-size:12.0pt;\">10,000</span></p>"
      },
      {
        "id": 43481,
        "text": "<p><span style=\"font-size:12.0pt;\">1,00,000</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A public health official notes that there were 60 infant deaths and 5,000 live births in the past year. What denominator should she use to calculate the infant mortality rate? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q9935799",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175484,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 1000</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infant Mortality Rate (IMR) is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-111122.jpg\" alt=\"\" width=\"900\" height=\"53\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The denominator of 1000 is used to standardize the rate for easy comparison across different regions and populations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-111310.jpg\" alt=\"\" width=\"900\" height=\"105\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SRS bulletin 2022 - India IMR: 28 per 1000 live births&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NFHS 5 (2019-21)- India IMR: 35 per 1000 live births&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(IMR of Kerala - 12 per 1000 live births and Japan 2 per 1000 live births)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The standard denominator for calculating and expressing the Infant Mortality Rate (IMR) is 1000 live births.</span></p>",
    "correct_choice_id": 43479,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10188,
    "choices": [
      {
        "id": 40718,
        "text": "<p><span style=\"font-size:18px;\">A person who sheds pathogens during incubation period</span></p>"
      },
      {
        "id": 40719,
        "text": "<p><span style=\"font-size:18px;\">A carrier who acquired pathogen from another carrier</span></p>"
      },
      {
        "id": 40720,
        "text": "<p><span style=\"font-size:18px;\">A person who acquired pathogen from patient</span></p>"
      },
      {
        "id": 40721,
        "text": "<p><span style=\"font-size:18px;\">A patient who became a carrier</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>The term \"paradoxical carrier\" is defined as:&nbsp;</strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q3691717",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175454,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) A carrier who acquired pathogen from another carrier</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A paradoxical carrier is defined as a carrier who has acquired a pathogen from another carrier, yet does not exhibit any signs or symptoms of the disease. This situation is paradoxical because the pathogen is typically transmitted directly from an infected patient to a new host, but in this case, it has been passed from one asymptomatic carrier to another. This type of carrier plays a significant role in the epidemiology of certain infectious diseases by perpetuating the transmission cycle without showing clinical symptoms themselves.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. A person who sheds pathogens during incubation period:&nbsp;</strong> This describes an incubatory carrier, who sheds infectious agents during the incubation period of the disease. This is different from a paradoxical carrier, as it involves shedding pathogens before symptoms appear.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. A person who acquired pathogen from patient:&nbsp;</strong> This does not describe a paradoxical carrier. It refers to a typical transmission scenario where a pathogen is acquired directly from an infected patient, rather than another asymptomatic carrier.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. A patient who became a carrier:&nbsp;</strong> This refers to a convalescent carrier or a chronic carrier. A convalescent carrier is someone who continues to shed the disease agent during the recovery period, while a chronic carrier harbors the pathogen long-term. Neither term is synonymous with a paradoxical carrier.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">A <strong>paradoxical carrier</strong> is a carrier who has acquired a pathogen from another carrier, but who does not show any signs or symptoms of the disease.</span></li><li><span style=\"font-size:18px;\"><strong>Incubatory carriers</strong> are those who shed the infectious agents during the incubation period of the disease.</span></li><li><span style=\"font-size:18px;\"><strong>Convalescent carriers</strong> are those who continue to shed the disease agent during the period of convalescence.</span></li><li><span style=\"font-size:18px;\"><strong>Healthy carriers</strong> are those who had a subclinical infection and developed a carrier state without suffering from overt disease.</span></li></ul>",
    "correct_choice_id": 40719,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10190,
    "choices": [
      {
        "id": 40726,
        "text": "<p><span style=\"font-size:18px;\">Goggles</span></p>"
      },
      {
        "id": 40727,
        "text": "<p><span style=\"font-size:18px;\">Gloves</span></p>"
      },
      {
        "id": 40728,
        "text": "<p><span style=\"font-size:18px;\">Face shield</span></p>"
      },
      {
        "id": 40729,
        "text": "<p><span style=\"font-size:18px;\">Lab coat</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which item below does not qualify as personal protective equipment? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q8746058",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175456,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Lab coat</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A lab coat is not a personal protective equipment.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">While lab coats are worn in laboratory settings to protect clothing and skin from spills and splashes, they are not classified as PPE. PPE refers to more specialized equipment designed to provide a barrier against specific hazards.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Other 3 options are considered as PPE</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Personal Protective Equipment (PPE) are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Gloves - protect hands.</span></li><li><span style=\"font-size:18px;\">Gowns/ aprons - protect skin and clothing.</span></li><li><span style=\"font-size:18px;\">Masks protect the mouth/nose and respirators protect the respiratory tract from airborne infectious agents.</span></li><li><span style=\"font-size:18px;\">Goggles - protect eyes.</span></li><li><span style=\"font-size:18px;\">Face shields - protect face, mouth, nose, and eyes.</span></li></ul>",
    "correct_choice_id": 40729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 11119,
    "choices": [
      {
        "id": 44442,
        "text": "<p><span style=\"font-size:18px;\">Specific protection</span></p>"
      },
      {
        "id": 44443,
        "text": "<p><span style=\"font-size:18px;\">Disability limitation</span></p>"
      },
      {
        "id": 44444,
        "text": "<p><span style=\"font-size:18px;\">Primary prevention</span></p>"
      },
      {
        "id": 44445,
        "text": "<p><span style=\"font-size:18px;\">Health promotion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>In the accompanying illustration, a treatment approach for a patient with lymphatic filariasis is depicted. Which type of preventive method is illustrated in this scenario?</strong> <i><strong>[INICET MAY 2022]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip27.jpg\" alt=\"\" width=\"400\" height=\"213\"></span></p>",
    "unique_key": "Q9876654",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175436,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Disability limitation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The image shows an established case of chronic lymphatic filariasis, where hygiene is being maintained to prevent further disability by secondary bacterial infection.</span></li><li><span style=\"font-size:18px;\">Disability limitation is a mode of intervention in tertiary prevention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Specific protection:&nbsp;</strong>Health promotion is a mode of intervention in primary prevention, and is the process of enabling people to increase control over, and improve health. Health promotion may be achieved through health education, environmental modification, nutritional <strong>interventions or lifestyle changes.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Primary prevention:</strong> Primary prevention is a level of prevention which is defined as action taken prior to the onset of a disease, which removes the possibility that a disease will ever occur. It is accomplished by measures designed to promote general health and well-being.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Health promotion:</strong> Specific protection is a mode of intervention in primary prevention which aims at limiting the number of cases of a particular disease. This includes immunization, use of specific nutrients, chemoprophylaxis, accident protection, and avoidance of allergens.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Disability limitation is a mode of tertiary prevention aimed at managing existing disease and preventing further complications, as illustrated in the treatment approach for a patient with chronic lymphatic filariasis in the image.</span></li></ul>",
    "correct_choice_id": 44443,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 46450,
    "choices": [
      {
        "id": 185419,
        "text": "<p><span style=\"font-size:12.0pt;\">Breast cancer</span></p>"
      },
      {
        "id": 185420,
        "text": "<p><span style=\"font-size:12.0pt;\">Cervical cancer</span></p>"
      },
      {
        "id": 185421,
        "text": "<p><span style=\"font-size:12.0pt;\">Ovarian cancer</span></p>"
      },
      {
        "id": 185422,
        "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female 29 years old is on a Combined OCP regimen for contraception. All of the following cancers may be seen in her except (FMGE JULY 2023)</span></p>",
    "unique_key": "Q2218756",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175474,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ovarian cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Combined Oral Contraceptive Pills (OCPs) have been shown to reduce the risk of ovarian cancer. OCPs are <strong>protective against benign breast diseases, benign &amp; malignant ovarian diseases </strong>but have been associated with an <strong>increased risk of breast cancer and cervical cancer</strong>. Thus, ovarian cancer is the correct answer, as it is the exception.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Breast cancer:</strong> Combined OCPs may slightly increase the risk of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cervical cancer:</strong> There is evidence that long-term use of combined OCPs can increase the risk of cervical cancer.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Combined Oral Contraceptive Pills reduce the risk of ovarian cancer while potentially increasing the risk of breast and cervical cancers.</span></p>",
    "correct_choice_id": 185421,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10187,
    "choices": [
      {
        "id": 40714,
        "text": "<p><span style=\"font-size:18px;\">1-2%</span></p>"
      },
      {
        "id": 40715,
        "text": "<p><span style=\"font-size:18px;\">4-8%</span></p>"
      },
      {
        "id": 40716,
        "text": "<p><span style=\"font-size:18px;\">8-10%</span></p>"
      },
      {
        "id": 40717,
        "text": "<p><span style=\"font-size:18px;\">12-14%</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>The risk of genetic diseases in consanguineous marriage between first cousins is?&nbsp;[NEET PG 2019]</strong></span></p>",
    "unique_key": "Q3940906",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175453,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 4-8%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The risk of genetic diseases in consanguineous marriage between first cousins is higher than in non-consanguineous marriages. The risk depends on several factors, such as the prevalence of genetic diseases in the population, the degree of consanguinity, and the genetic makeup of the couple.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The estimated risk of genetic diseases in consanguineous marriage between first cousins is around 4-8%, which is higher than the general population's risk of around 2-4%. However, the risk can vary widely depending on the specific genetic diseases and the population's prevalence.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The risk of genetic diseases in consanguineous marriage between first cousins is estimated to be around 4-8%, which is higher than the general population risk of approximately 2-4%.</span></p>",
    "correct_choice_id": 40715,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 57597,
    "choices": [
      {
        "id": 229757,
        "text": "<p><span style=\"font-size:18px;\">Start breastfeeding as soon as possible</span></p>"
      },
      {
        "id": 229758,
        "text": "<p><span style=\"font-size:18px;\">Clear eyes with a sterile swab</span></p>"
      },
      {
        "id": 229759,
        "text": "<p><span style=\"font-size:18px;\">Bath to newborn with warm water</span></p>"
      },
      {
        "id": 229760,
        "text": "<p><span style=\"font-size:18px;\">Cover baby\u2019s head and body</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A mother delivers in a rural area under the guidance of a skilled birth attendant. Incorrect regarding the care provided by the skilled birth attendant is: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q9462199",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175483,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Bath to newborn with warm water</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Bathing a newborn immediately after birth is not recommended as it can cause rapid heat loss and hypothermia in the infant. Instead, after delivery, the newborn should be wiped clean with a sterile cloth and wrapped warmly without giving a bath. The bath can be delayed until at least 24 hours after birth or later when the baby\u2019s body temperature has stabilized, especially in settings without advanced care facilities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Start breastfeeding as soon as possible</strong>: It is recommended to initiate breastfeeding immediately after birth, ideally within the first hour for vaginal deliveries and within 4 hours for cesarean sections. Early breastfeeding provides the newborn with essential nutrients and antibodies and helps stimulate milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Clear eyes with a sterile swab</strong>: Clearing the eyes of a newborn with a sterile swab is correct. If needed, antiseptic solutions like <strong>1% silver nitrate or 1% tetracycline ointment</strong> can be used to prevent ophthalmia neonatorum, an eye infection that can occur in newborns.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Cover baby\u2019s head and body</strong>: Covering the baby\u2019s head and body immediately after birth is essential to prevent heat loss. Newborns lose up to 75% of their body heat through the head, making it crucial to keep the baby warm.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Newborns should not be bathed immediately after birth to prevent hypothermia; instead, they should be wiped clean and kept warm by wrapping them appropriately.</span></p>",
    "correct_choice_id": 229759,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57599,
    "choices": [
      {
        "id": 229765,
        "text": "<p><span style=\"font-size:18px;\">Zinc deficiency</span></p>"
      },
      {
        "id": 229766,
        "text": "<p><span style=\"font-size:18px;\">Iron deficiency</span></p>"
      },
      {
        "id": 229767,
        "text": "<p><span style=\"font-size:18px;\">Selenium deficiency</span></p>"
      },
      {
        "id": 229768,
        "text": "<p><span style=\"font-size:18px;\">Copper deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A child presented to PHC OPD with skin rash and depigmented hair. He gives a history of swollen/bleeding gums. X-ray picture is shown below. He is suffering from: </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174412.jpg\" alt=\"\" width=\"400\" height=\"284\"></strong></span></p>",
    "unique_key": "Q1497190",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175485,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Copper deficiency</strong></span></p><p><br><span style=\"font-size:18px;\">The clinical presentation of the child, including skin rash, depigmented hair, swollen/bleeding gums, and the X-ray findings, suggests a deficiency that closely mimics scurvy (vitamin C deficiency). However, in this question, the exact cause is copper deficiency, which shares similar symptoms and radiological appearances with scurvy. Copper plays a crucial role in various metabolic pathways, including those influenced by vitamin C, such as collagen synthesis and connective tissue health. Copper deficiency is known as pseudoscurvy because it presents with nearly identical clinical and radiological features as vitamin C deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Zinc deficiency: </strong>Zinc deficiency typically presents with symptoms such as delayed wound healing, immune dysfunction, and dermatitis, particularly around orifices. It does not cause the specific combination of bleeding gums, depigmented hair, and the radiological changes observed in the X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Iron deficiency: </strong>Iron deficiency usually presents with symptoms related to anemia, such as fatigue, pallor, and pica. While it can cause brittle nails and hair changes, it does not present with bleeding gums and specific X-ray findings as seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Selenium deficiency: </strong>Selenium deficiency primarily affects the heart and muscles, leading to conditions like Keshan disease (cardiomyopathy) and muscle weakness. It does not cause the bleeding gums, depigmented hair, or the bone abnormalities observed in the X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">Copper deficiency can mimic vitamin C deficiency (scurvy) in its clinical and radiological presentation, a condition often referred to as pseudoscurvy.</span></p>",
    "correct_choice_id": 229768,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11067,
    "choices": [
      {
        "id": 44234,
        "text": "<p><span style=\"font-size:18px;\">Epidemic</span></p>"
      },
      {
        "id": 44235,
        "text": "<p><span style=\"font-size:18px;\">Endemic</span></p>"
      },
      {
        "id": 44236,
        "text": "<p><span style=\"font-size:18px;\">Sporadic</span></p>"
      },
      {
        "id": 44237,
        "text": "<p><span style=\"font-size:18px;\">Outbreak</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>As the in-charge epidemiologist of an urban CHC, you've been reviewing the weekly infectious disease reports. In a particular community under your jurisdiction, you observe that dengue case counts typically range from 40 to 50 cases every week. During your current weekly review, you note there are 48 reported cases of dengue. Based on this data and your understanding of epidemiological terminology, how would you classify this week's situation with respect to dengue? </strong><i><strong>[AIIMS MAY 2018]</strong></i></span></p>",
    "unique_key": "Q8932902",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175450,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Endemic&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The given scenario is an example of an endemic disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Endemic</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Endemic: Constant presence of a disease or infectious agent in a defined geographical area. It is the \u2018usual or expected frequency\u2019 of a disease in a population</span></li><li><span style=\"font-size:18px;\">Types of Endemic:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">Hyper-endemic: Constant presence of a disease or infectious agent at high incidence/prevalence AND affects all age groups equally</span></li><li><span style=\"font-size:18px;\">Holo-endemic: A high level of infection beginning early in life AND affecting most of the children population</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Epidemic:</strong> Incorrect because an epidemic refers to an increase in the number of cases of a disease beyond what is normally expected in that population in that area. The current case count does not exceed the usual range.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Sporadic:</strong> Incorrect because sporadic refers to a disease that occurs infrequently and irregularly; here, the cases are neither infrequent nor irregular.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Outbreak:</strong> Similar to an epidemic, an outbreak implies a greater-than-anticipated increase in the number of cases within a small, localized area over a short period. Again, since the case count is within normal expectations, this term does not apply.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Endemic: Is the \u2018usual or expected frequency\u2019 of a disease in a population</span></li></ul>",
    "correct_choice_id": 44235,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 10248,
    "choices": [
      {
        "id": 40958,
        "text": "<p><span style=\"font-size:18px;\">History of similar illness in the past</span></p>"
      },
      {
        "id": 40959,
        "text": "<p><span style=\"font-size:18px;\">History of fever</span></p>"
      },
      {
        "id": 40960,
        "text": "<p><span style=\"font-size:18px;\">History of vaccination</span></p>"
      },
      {
        "id": 40961,
        "text": "<p><span style=\"font-size:18px;\">History of diet</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A man from Chhattisgarh presented with a gradual onset of muscle weakness and spasms in his legs. Upon examination, he exhibited a specific loss of motor function. What inquiries should be made to gather the most relevant medical history from this patient? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
    "unique_key": "Q3775847",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175437,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) History of diet</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The clinical presentation suggests that the patient may have neurolathyrism, which is caused by the excessive consumption of Lathyrus sativus or Khesari dal.</span></li><li><span style=\"font-size:18px;\">To confirm the diagnosis, it is important to obtain the patient's dietary history.</span></li><li><span style=\"font-size:18px;\">Neurolathyrism is a paralytic condition caused by the consumption of Lathyrus sativus or Khesari dal, which is common in certain regions of India such as Madhya Pradesh, Uttar Pradesh, Chhattisgarh, Odisha, and Bihar.</span></li><li><span style=\"font-size:18px;\">The disease mainly affects the nervous system, causing gradual spastic paralysis of the lower limbs. It primarily affects males between the ages of 15 and 45 years and progresses through several stages.</span></li><li><span style=\"font-size:18px;\">The toxin responsible for the disease is BOAA (Beta oxalyl amino alanine), which is water-soluble and can be removed from the pulses by soaking them in hot water and discarding the water.</span></li><li><span style=\"font-size:18px;\">Large-scale detoxification can be achieved by parboiling the crop, or by overnight soaking in lime water followed by boiling.</span></li><li><span style=\"font-size:18px;\">Vitamin C in doses of 500-1000mg can help prevent and treat lathyrism.</span></li><li><span style=\"font-size:18px;\">In India, the Prevention of Food Adulteration Act prohibits the use of Lathyrus sativus in any form (whole/split/flour).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/04/screenshot-2023-10-04-111207.jpg\" alt=\"\" width=\"300\" height=\"322\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-144311.png\" alt=\"\" width=\"1000\" height=\"333\"></span></p>",
    "correct_choice_id": 40961,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 44291,
    "choices": [
      {
        "id": 176815,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
      },
      {
        "id": 176816,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
      },
      {
        "id": 176817,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin E</span></p>"
      },
      {
        "id": 176818,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Bowing of legs with bleeding gums is seen in:</span></p>",
    "unique_key": "Q2711506",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175429,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bowing of legs can be mistakenly attributed to vitamin D deficiency, which typically causes rickets in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, the presence of bleeding gums points specifically to vitamin C deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin C is crucial for collagen synthesis and other structural aspects of bone formation. This deficiency, known as scurvy, involves various skeletal changes including defective osteoid matrix formation and osteolysis, beyond just the commonly noted bleeding gums. The combined symptoms of bowing of legs and bleeding gums can indeed suggest a scenario where vitamin C deficiency plays a contributory role alongside other deficiencies like vitamin D.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>B. Vitamin A:</strong> Incorrect because Vitamin A deficiency primarily affects vision and epithelial tissues, not typically associated with bleeding gums or significant skeletal changes like bowing of legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>C. Vitamin E:</strong> Incorrect as Vitamin E deficiency generally leads to neurological problems and muscle weakness, not directly linked with bleeding gums or bone deformities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>D. Vitamin K:</strong> Incorrect because while Vitamin K is essential for blood clotting, its deficiency is not typically associated with bowing of legs; it would rather lead to bleeding issues without the skeletal deformities noted here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin C deficiency can cause bleeding gums and is associated with significant bone structure changes, leading to conditions like scurvy that may present with skeletal deformities such as bowing of legs.</span></p>",
    "correct_choice_id": 176815,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 44290,
    "choices": [
      {
        "id": 176811,
        "text": "<p><span style=\"font-size:12.0pt;\">60 mg iron and 500 mcg folic acid twice a week</span></p>"
      },
      {
        "id": 176812,
        "text": "<p><span style=\"font-size:12.0pt;\">60 mg iron and 500 mcg folic acid once a week</span></p>"
      },
      {
        "id": 176813,
        "text": "<p><span style=\"font-size:12.0pt;\">60 mg iron and 500 mcg folic acid daily</span></p>"
      },
      {
        "id": 176814,
        "text": "<p><span style=\"font-size:12.0pt;\">60 mg iron and 500 mcg folic acid once a month</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What dose of iron and folic acid should an anemic pregnant woman in her 2nd trimester be given? (FMGE JANUARY 2024</span></p>",
    "unique_key": "Q9608881",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175428,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 60 mg iron and 500 mcg folic acid daily</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the Anemia Mukt Bharat program, which aims to reduce the prevalence of anemia in India by 3 percentage points every year, the \"6 by 6 by 6\" strategy is used. This strategy targets 6 beneficiaries, includes 6 interventions, and involves 6 institutional mechanisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/20/image-3.jpg\" alt=\"\" width=\"400\" height=\"347\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">One of the interventions is iron and folic acid supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anemic pregnant women in their second trimester should be given 60 mg of elemental iron and 500 mcg of folic acid daily for 180 days, as per the guidelines of the Anemia Mukt Bharat program.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For pregnant women, the recommended dose is <strong>60 mg of elemental iron and 500 mcg of folic acid daily for 180 days </strong>during pregnancy. This is provided in the form of red-colored tablets. The same dose is also given to lactating mothers for 180 days post-delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If the woman does not respond to this dosage or is anemic, then other forms of iron supplementation, such as <strong>ferrous carboxy maltose and IV sucrose</strong>, may be considered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/20/screenshot-2024-05-20-112451.JPG\" alt=\"\" width=\"1000\" height=\"521\"></strong></span></p>",
    "correct_choice_id": 176813,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 10883,
    "choices": [
      {
        "id": 43498,
        "text": "<p><span style=\"font-size:12.0pt;\">Stage 1</span></p>"
      },
      {
        "id": 43499,
        "text": "<p><span style=\"font-size:12.0pt;\">Stage 2</span></p>"
      },
      {
        "id": 43500,
        "text": "<p><span style=\"font-size:12.0pt;\">Stage 3</span></p>"
      },
      {
        "id": 43501,
        "text": "<p><span style=\"font-size:12.0pt;\">Stage 4</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A public health researcher is analyzing demographic patterns in a tribal region of Jharkhand, India. The community has high birth and death rates due to limited healthcare and high disease prevalence. In which stage of the demographic transition model is the birth rate typically the highest?&nbsp;&nbsp;(FMGE JAN 2023)</span></p>",
    "unique_key": "Q2985870",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175431,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Stage 1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The highest birth rate is observed in Stage 1 of the demographic cycle, characterized by both high birth and high death rates due to limited healthcare and high disease prevalence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Five stages of the demographic cycle: -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stage 1: (High Stationary): High Birth Rate &amp; High Death Rate</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stage 2: (Early Expanding): Birth Rate Unchanged &amp; Death Rate Decrease</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stage3: (Late Expanding): Birth Rate: Decreases &amp; Death Rate: Decreases</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stage 4: (Late Stationary): BR: Low &amp; DR: Low</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Stage 5: (Declining): BR &lt; DR/Population Decreases</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-112928.jpg\" alt=\"\" width=\"700\" height=\"496\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Five stages of demographic cycle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-112955.jpg\" alt=\"\" width=\"700\" height=\"552\"></strong></span></p>",
    "correct_choice_id": 43498,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10216,
    "choices": [
      {
        "id": 40830,
        "text": "<p><span style=\"font-size:18px;\">Relative risk</span></p>"
      },
      {
        "id": 40831,
        "text": "<p><span style=\"font-size:18px;\">Attributable risk</span></p>"
      },
      {
        "id": 40832,
        "text": "<p><span style=\"font-size:18px;\">Population Attributable risk</span></p>"
      },
      {
        "id": 40833,
        "text": "<p><span style=\"font-size:18px;\">Odds Ratio</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of the following variables indicates the difference between the incidence of disease among exposed and incidence among non-exposed?</strong><i><strong> [NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q3871165",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175466,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Attributable risk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The difference between the incidence of disease among exposed and the incidence among non-exposed is given by the attributable risk. Attributable risk is the difference in risk of disease between two groups (exposed and non-exposed) and represents the proportion of disease occurrence that can be attributed to the exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173720_vY5TP7I.jpg\" alt=\"\" width=\"811\" height=\"66\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.&nbsp; Relative risk:&nbsp;</strong>Is a measure of the strength of association between exposure and disease, and it compares the risk of disease in exposed individuals to the risk in non-exposed individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Population attributable risk:&nbsp;</strong>Is a measure of the Incidence of the disease that is likely to be reduced if the risk factor is modified/eliminated.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173900_fDr5Jo4.jpg\" alt=\"\" width=\"769\" height=\"62\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Odds ratio:&nbsp;</strong>Is a measure of the odds of exposure among cases compared to the odds of exposure among controls in a case-control study.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Attributable risk is the metric that indicates the difference in the incidence of disease between exposed and non-exposed groups, representing the proportion of disease occurrence attributable to the exposure.</span></p>",
    "correct_choice_id": 40831,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 46428,
    "choices": [
      {
        "id": 185331,
        "text": "<p><span style=\"font-size:12.0pt;\">Rape</span></p>"
      },
      {
        "id": 185332,
        "text": "<p><span style=\"font-size:12.0pt;\">Contraceptive failure</span></p>"
      },
      {
        "id": 185333,
        "text": "<p><span style=\"font-size:12.0pt;\">Foetus malformation</span></p>"
      },
      {
        "id": 185334,
        "text": "<p><span style=\"font-size:12.0pt;\">Insanity</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As per the new guidelines of MTP Act, Medical termination of pregnancy can be done after 24 weeks for?</span></p>",
    "unique_key": "Q9478058",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175460,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Foetus malformation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">According to the new guidelines of the Medical Termination of Pregnancy (MTP) Act, as amended in 2021, medical termination of pregnancy is permitted in India up to 24 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Beyond 24 weeks</strong>, MTP is permissible in cases where there are documented <strong>substantial fetal anomalies or malformations</strong>. In such cases, the opinion of the <strong>state medical board</strong> is required to proceed with the termination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Rape: </strong>This option is incorrect because, while rape or sexual assault is one of the indications for MTP up to 24 weeks, it is not a specific indication for MTP beyond 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Contraceptive failure:</strong> This option is incorrect because contraceptive failure is a social indication for MTP up to 24 weeks, but it is not a specific indication for MTP beyond 24 weeks.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Insanity:</strong> This option is incorrect as it is not mentioned as an indication for MTP beyond 24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per the new guidelines of the MTP Act in India, medical termination of pregnancy can be performed beyond 24 weeks of gestation only in cases of documented substantial fetal anomalies or malformations, and the opinion of the state medical board is required.</span></p>",
    "correct_choice_id": 185333,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10249,
    "choices": [
      {
        "id": 40962,
        "text": "<p><span style=\"font-size:18px;\">BCG</span></p>"
      },
      {
        "id": 40963,
        "text": "<p><span style=\"font-size:18px;\">MMR</span></p>"
      },
      {
        "id": 40964,
        "text": "<p><span style=\"font-size:18px;\">TT/Td</span></p>"
      },
      {
        "id": 40965,
        "text": "<p><span style=\"font-size:18px;\">DPT</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which vaccine is administered as part of the immunization program to a 10-year-old school child? </strong><i><strong>[NEET PG 2021]</strong></i></span></p>",
    "unique_key": "Q8789566",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175435,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) TT/Td</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Based on the situation provided, a ten-year-old student is recommended to receive the TT/Td vaccine as per the National Immunization Schedule.</span></li><li><span style=\"font-size:18px;\">The Td vaccine is a combination of tetanus and diphtheria vaccines, with a lower concentration of diphtheria antigen, and is recommended for older children and adults.</span></li><li><span style=\"font-size:18px;\">The Ministry of Health and Family Welfare (MoHFW) advises the use of Td vaccine for all age groups, including pregnant women. A dose of 0.5ml is injected into the upper arm muscle. This vaccine is given at the age of 10 and 16.</span></li><li><span style=\"font-size:18px;\">For pregnant women, Td-1 is given early in pregnancy and Td-2 is given 4 weeks after Td-1. A Td booster shot is recommended if a pregnancy occurs within 3 years of the last pregnancy and 2 Td doses were previously received.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>NEW National Immunization Schedule (NIS) 2023-24</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-144426.png\" alt=\"\" width=\"1000\" height=\"477\"></span></p>",
    "correct_choice_id": 40964,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 44292,
    "choices": [
      {
        "id": 176819,
        "text": "<p><span style=\"font-size:12.0pt;\">0.01%</span></p>"
      },
      {
        "id": 176820,
        "text": "<p><span style=\"font-size:12.0pt;\">0.05%</span></p>"
      },
      {
        "id": 176821,
        "text": "<p><span style=\"font-size:12.0pt;\">0.8%</span></p>"
      },
      {
        "id": 176822,
        "text": "<p><span style=\"font-size:12.0pt;\">1%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Xerophthalmia is considered a public health problem if the prevalence of bitot's spot is more than: (FMGE JANUARY 2024)</span></p>",
    "unique_key": "Q9996912",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175432,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 0.8%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">One of the criteria for considering xerophthalmia as a public health problem is if the prevalence of bitot's spots (a sign of vitamin A deficiency) is <strong>more than 0.5%</strong> in the population. The specifically asks about the prevalence of bitot's spots, and the option closest to 0.5% is 0.8%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Prevalence criteria for determining the Xerophthalmia problem in a community: (Preschool children 6 months- 6 years).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/20/screenshot-2024-05-20-112533.JPG\" alt=\"\" width=\"1000\" height=\"444\"></strong></span></p>",
    "correct_choice_id": 176821,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "FMGE"
    ]
  },
  {
    "id": 57588,
    "choices": [
      {
        "id": 229721,
        "text": "<p><span style=\"font-size:18px;\">Meena, TB</span></p>"
      },
      {
        "id": 229722,
        "text": "<p><span style=\"font-size:18px;\">Mala, Malaria</span></p>"
      },
      {
        "id": 229723,
        "text": "<p><span style=\"font-size:18px;\">Sapna, Leprosy</span></p>"
      },
      {
        "id": 229724,
        "text": "<p><span style=\"font-size:18px;\">Meera, HIV</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which disease the girl is related to and what's her name? </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-173835.jpg\" alt=\"\" width=\"300\" height=\"514\"></strong></span></p><p>&nbsp;</p>",
    "unique_key": "Q4411191",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175478,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Sapna, Leprosy</strong></span></p><p><br><span style=\"font-size:18px;\">The girl in the image is named Sapna, and she is associated with the National Leprosy Eradication Program. Sapna is an emblematic figure used to raise awareness about leprosy prevention and control through information, education, and communication (IEC) strategies. She symbolizes the message that leprosy is completely curable. Sapna herself is portrayed as a former leprosy patient who has been fully cured, aiming to reduce stigma and educate the public about the disease's curability.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">National Leprosy Mission Trust of India is the agency who came out with the concept of the girl Sapna for Leprosy Awareness Efforts Generation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">Sapna is a character created to promote leprosy awareness and emphasize that leprosy is a 100% curable disease.</span></p>",
    "correct_choice_id": 229723,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10152,
    "choices": [
      {
        "id": 40574,
        "text": "<p><span style=\"font-size:18px;\">Calcium carbonate</span></p>"
      },
      {
        "id": 40575,
        "text": "<p><span style=\"font-size:18px;\">Calcium sulphate</span></p>"
      },
      {
        "id": 40576,
        "text": "<p><span style=\"font-size:18px;\">Calcium bicarbonate</span></p>"
      },
      {
        "id": 40577,
        "text": "<p><span style=\"font-size:18px;\">Magnesium bicarbonate</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of the options below does not result in water hardness? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
    "unique_key": "Q9315160",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175446,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Calcium carbonate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hardness of water is caused by the presence of dissolved minerals, particularly calcium and magnesium ions. These minerals can come from various sources, such as natural deposits in soil and rocks, or from industrial and domestic activities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">There are two types of hardness of water:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Temporary&nbsp;</strong>(carbonate) hardness is due to bicarbonates of calcium and magnesium.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Permanent</strong> (non-carbonate) hardness is due to sulphates, chlorides and nitrates.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Hardness of water is defined as the \u2018soap destroying power of water\u2019</span></li><li><span style=\"font-size:18px;\">Hardness of water is expressed in terms of: milliequivalents per litre (mEq/litre) of CALCIUM CARBONATE (CaCO3)</span></li><li><span style=\"font-size:18px;\">1 mEq/litre hardness = 50 mg CaCO3 (50 ppm) per litre of water</span></li><li><span style=\"font-size:18px;\">Softening of water is recommended at level of hardness &gt; 3 mEq/litre (&gt;150 mg/litre of Calcium carbonate)</span></li><li><span style=\"font-size:18px;\">Temporary hardness of water is due to Ca++ and Mg++ Bicarbonates</span></li><li><span style=\"font-size:18px;\">Permanent hardness (Non-Carbonate hardness) is due to Calcium &amp; Magnesium salts of Sulfates, Chlorides, Nitrates</span></li><li><span style=\"font-size:18px;\">Four main compounds causing Hardness: Calcium bicarbonates, Magnesium bicarbonates, Calcium sulfates, Magnesium sulfates.</span></li></ul>",
    "correct_choice_id": 40574,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 11146,
    "choices": [
      {
        "id": 44550,
        "text": "<p><span style=\"font-size:18px;\">Liposomal Amphotericin B</span></p>"
      },
      {
        "id": 44551,
        "text": "<p><span style=\"font-size:18px;\">Fluconazole</span></p>"
      },
      {
        "id": 44552,
        "text": "<p><span style=\"font-size:18px;\">Linezolid</span></p>"
      },
      {
        "id": 44553,
        "text": "<p><span style=\"font-size:18px;\">Bedaquiline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 38-year-old man from a rural area of Bihar presents to the outpatient department of a tertiary care hospital in Patna. He has been experiencing fever for the past week, associated with abdominal distension, loss of appetite, and palpable lymphadenopathy. Despite being treated with broad-spectrum antibiotics and antimalarial agents by a local practitioner, there's been no significant relief. Blood investigations for typhoid (Widal test) are negative; however, the rk39 dipstick test is positive. Based on the clinical picture and the diagnostic findings, what would be the most appropriate drug of choice for the treatment of his condition?&nbsp;</strong><i><strong>[AIIMS NOV 2018]</strong></i></span></p>",
    "unique_key": "Q5035505",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175438,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Liposomal Amphotericin B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">This clinical presentation strongly indicates the diagnosis of visceral leishmaniasis.</span></li><li><span style=\"font-size:18px;\">The recommended course of action for this patient involves the administration of liposomal amphotericin B.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-121923.png\" alt=\"\" width=\"1000\" height=\"305\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Incubation Period: 10 days to 2 years (average 1 \u2013 4 months)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serological tests:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">ELISA: for diagnosis as well as epidemiological field survey</span></li><li><span style=\"font-size:18px;\">rk 39 dipstick test</span></li><li><span style=\"font-size:18px;\">Indirect Flourescent Antibody Test (IFAT)</span></li><li><span style=\"font-size:18px;\">Direct Agglutination Test</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">&nbsp;Treatment of Leishmaniasis</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Sodium stibogluconate</span></li><li><span style=\"font-size:18px;\">Miltefosine</span></li><li><span style=\"font-size:18px;\">Paramomycin</span></li><li><span style=\"font-size:18px;\">Liposomal Amphotericin B (DOC)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B</strong>: Fluconazole is an anti-fungal, not useful in visceral leishmaniasis</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C</strong>: Linezolid is used in the treatment of MRSA</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D</strong>: Bedaquiline is a newer anti-TB drug used in MDR-TB.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Visceral leishmaniasis (Kala Azar) should be treated with liposomal amphotericin B, especially when diagnosed with a positive rk39 dipstick test.</span></li></ul>",
    "correct_choice_id": 44550,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 10222,
    "choices": [
      {
        "id": 40854,
        "text": "<p><span style=\"font-size:18px;\">H1N1</span></p>"
      },
      {
        "id": 40855,
        "text": "<p><span style=\"font-size:18px;\">H5N1</span></p>"
      },
      {
        "id": 40856,
        "text": "<p><span style=\"font-size:18px;\">H5N7</span></p>"
      },
      {
        "id": 40857,
        "text": "<p><span style=\"font-size:18px;\">H3N2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>Which influenza virus was responsible for the 2009 pandemic? </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q7430246",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175470,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) H1N1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The 2009 influenza pandemic, commonly referred to as the \"swine flu\" pandemic, was caused by the H1N1 influenza A virus. This virus emerged in Mexico and quickly spread worldwide, causing widespread illness and leading to a global pandemic.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>H5N1:&nbsp;</strong>Known as the \"bird flu\" virus.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Year:&nbsp;</strong>First identified in 1997 in Hong Kong.</span></li><li><span style=\"font-size:18px;\"><strong>Impact:&nbsp;</strong>Primarily affects birds but can infect humans, causing severe respiratory illness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>H5N7:&nbsp;</strong>This subtype of influenza is not known to have caused any major pandemics or widespread outbreaks in humans.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>H3N2:&nbsp;</strong>This subtype of influenza A virus is known to cause seasonal flu epidemics but was not responsible for the 2009 pandemic.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Year:&nbsp;</strong>H3N2 was involved in the 1968 influenza pandemic, known as the \"Hong Kong flu.\"</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Influenza Pandemics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">SWINE FLU, H1N1 \u2192 2009, Mexico</span></p><p><span style=\"font-size:18px;\">BIRD FLU, H7N9 \u2192 2013, China</span></p><p><span style=\"font-size:18px;\">BIRD FLU, H5N1 \u2192 1997, Hong Kong</span></p><p><span style=\"font-size:18px;\">BIRD FLU, H10N3 \u2192 2021, China</span></p>",
    "correct_choice_id": 40854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10219,
    "choices": [
      {
        "id": 40842,
        "text": "<p><span style=\"font-size:18px;\">Full course of tetanus vaccination</span></p>"
      },
      {
        "id": 40843,
        "text": "<p><span style=\"font-size:18px;\">Single dose tetanus toxoid</span></p>"
      },
      {
        "id": 40844,
        "text": "<p><span style=\"font-size:18px;\">Tetanus toxoid + immunoglobulin</span></p>"
      },
      {
        "id": 40845,
        "text": "<p><span style=\"font-size:18px;\">No vaccination needed</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A patient arrives with a clean-cut injury, no lacerations. He reports receiving his last tetanus vaccination approximately a decade ago. What would be the recommended course of action?</strong><i><strong> [NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q9316361",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175468,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Single dose tetanus toxoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The recommended course of action for a patient with a clean-cut injury who received their last tetanus vaccination approximately a decade ago is to administer a single dose of tetanus toxoid. This recommendation is based on the standard guidelines for tetanus prophylaxis in wound management.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173902.jpg\" alt=\"\" width=\"800\" height=\"380\"></span></p>",
    "correct_choice_id": 40843,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 10880,
    "choices": [
      {
        "id": 43486,
        "text": "<p><span style=\"font-size:12.0pt;\">Wound care +IM vaccine + Rabies serum</span></p>"
      },
      {
        "id": 43487,
        "text": "<p><span style=\"font-size:12.0pt;\">Wound care + IM vaccine 0,3</span></p>"
      },
      {
        "id": 43488,
        "text": "<p><span style=\"font-size:12.0pt;\">Wound care + IM vaccine 0.3 7</span></p>"
      },
      {
        "id": 43489,
        "text": "<p><span style=\"font-size:12.0pt;\">Wound care only</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 35-year-old woman is bitten by a stray dog. She had received post-exposure prophylaxis for a monkey bite two months ago. What is the appropriate management for her current rabies exposure? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q6019303",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175426,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Wound care + IM vaccine 0,3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As patient has already received post-exposure prophylaxis for monkey bite, she should receive Re-exposure prophylaxis in the form of 2 doses of vaccine on days 0 &amp; 3 along with wound care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Post-Exposure Prophylaxis (PEP)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Wound Care - Immediate care&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thorough washing and flushing of the wound for approximately 15 minutes, with soap or detergent and copious amounts of water, is required; Where available, an iodine-containing, or similarly viricidal, topical preparation should be applied to the wound</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>WHO Rabies Exposure Categories</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Category I: Touching or feeding animals, animal licks on intact skin (no exposure)</span></li><li><span style=\"font-size:12.0pt;\">Category II: Nibbling of uncovered skin, minor scratches or abrasions without bleeding (exposure)</span></li><li><span style=\"font-size:12.0pt;\">Category III: Single or multiple transdermal bites or scratches, contamination of mucous membrane or broken skin with saliva from animal licks, exposures due to direct contact with bats (severe exposure)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>PEP Recommendations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/06/screenshot-2024-08-06-112007.jpg\" alt=\"\" width=\"1000\" height=\"558\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rabies Immunoglobulin (RIG) Administration</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">There are 2 types of RIG available for passive immunisation: human rabies immunoglobulin (hRIG) and equine rabies immunoglobulin (eRIG). Both hRIG and eRIG are equally effective and safe. But eRIG is less costly than hRIG</span></li><li><span style=\"font-size:12.0pt;\">Maximum dose: 20 IU (hRIG) and 40 IU (eRIG) per kg body weight</span></li><li><span style=\"font-size:12.0pt;\">Given only once, as soon as possible and not beyond Day 7 after the first dose of vaccine.</span></li><li><span style=\"font-size:12.0pt;\">Infiltrate as much as possible into the wound; the remainder of the calculated dose of RIG does not need to be injected IM at a distance from the wound but can be fractionated in smaller, individual syringes to be used for other patients, aseptic retention given.</span></li><li><span style=\"font-size:12.0pt;\">If RIG is not available, thorough, prompt wound washing, together with immediate administration of the first vaccine dose, followed by a complete course of rabies vaccine.</span></li><li><span style=\"font-size:12.0pt;\">Vaccines should never be withheld, regardless of the availability of RIG</span></li><li><span style=\"font-size:12.0pt;\">If a limited amount of RIG is available, RIG allocation should be prioritized for exposed patients based on the following criteria:&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Multiple bites&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Deep wounds</span></li><li><span style=\"font-size:12.0pt;\">Bites to highly innervated parts of the body (such as head, neck and hands)</span></li><li><span style=\"font-size:12.0pt;\">Severe immunodeficiency</span></li><li><span style=\"font-size:12.0pt;\">Biting animal is a confirmed or probable rabies case.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Bites, scratches or exposures of mucous membranes caused by a bat.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For individuals with a recent history of rabies vaccination (within the past three months), re-exposure prophylaxis includes wound care and two doses of the rabies vaccine on days 0 and 3.</span></p>",
    "correct_choice_id": 43487,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 10150,
    "choices": [
      {
        "id": 40566,
        "text": "<p><span style=\"font-size:18px;\">8/100</span></p>"
      },
      {
        "id": 40567,
        "text": "<p><span style=\"font-size:18px;\">2/1000</span></p>"
      },
      {
        "id": 40568,
        "text": "<p><span style=\"font-size:18px;\">4/1000</span></p>"
      },
      {
        "id": 40569,
        "text": "<p><span style=\"font-size:18px;\">8/1000</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What is the prevalence of a disease with an incidence of a disease of 4 cases per 1000 individuals in the population and an average duration of 2 years? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
    "unique_key": "Q1928652",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175444,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) 8/1000</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Prevalence represents the total number of cases of a disease in a population at a given time. It can be calculated using the relationship between incidence (the rate of new cases) and the average duration of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Given that the incidence of the disease is 4 per 1000 of the population, and the average duration of the disease is 2 years, we can calculate the prevalence as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Prevalence = 4/1000 x 2 = <strong>8/1000</strong> or 0.8%</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The prevalence can be calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Prevalence = Incidence x Duration.</strong></span></p>",
    "correct_choice_id": 40569,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10189,
    "choices": [
      {
        "id": 40722,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis A</span></p>"
      },
      {
        "id": 40723,
        "text": "<p><span style=\"font-size:18px;\">Hepatitis B</span></p>"
      },
      {
        "id": 40724,
        "text": "<p><span style=\"font-size:18px;\">Rabies</span></p>"
      },
      {
        "id": 40725,
        "text": "<p><span style=\"font-size:18px;\">Varicella</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which vaccine among the options is not recommended for use during pregnancy? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q6042780",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175455,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Varicella</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Varicella vaccine is contraindicated in pregnant women because it is a live attenuated vaccine. Live vaccines contain weakened forms of the virus, which can potentially cross the placenta and infect the fetus, leading to congenital infection or other complications. The primary concern is that the live virus, although weakened, may still pose a risk to the developing fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Live vaccines are generally avoided during pregnancy to minimize any potential risks to the fetus. Pregnant women are advised to receive inactivated vaccines, which do not contain live pathogens and are considered safer for both the mother and the unborn child.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Hepatitis A:</strong> &nbsp;The Hepatitis A vaccine is an inactivated (killed) vaccine. It is generally considered safe during pregnancy and can be administered if the benefits outweigh the risks, especially if the woman is at high risk for Hepatitis A infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Hepatitis B:&nbsp;</strong> The Hepatitis B vaccine is a recombinant vaccine, which does not contain live virus. It is safe to use during pregnancy and is recommended for pregnant women who are at risk of Hepatitis B infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Rabies:&nbsp;</strong> The Rabies vaccine is an inactivated vaccine. It is considered safe during pregnancy and should be administered if there is a risk of rabies exposure, as the disease itself is fatal if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125429.jpg\" alt=\"\" width=\"794\" height=\"652\"></span></p>",
    "correct_choice_id": 40725,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10154,
    "choices": [
      {
        "id": 40582,
        "text": "<p><span style=\"font-size:18px;\">2 weeks</span></p>"
      },
      {
        "id": 40583,
        "text": "<p><span style=\"font-size:18px;\">4 weeks</span></p>"
      },
      {
        "id": 40584,
        "text": "<p><span style=\"font-size:18px;\">8 weeks</span></p>"
      },
      {
        "id": 40585,
        "text": "<p><span style=\"font-size:18px;\">12 weeks</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What is the recommended time gap between the application of two live vaccines? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
    "unique_key": "Q4644900",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175448,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 4 weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">According to the guidelines of the World Health Organization (WHO), there should be a minimum interval of 4 weeks (28 days) between the administration of two live vaccines.</span></li><li><span style=\"font-size:18px;\">This is to ensure that the immune system has enough time to respond to each vaccine and generate an adequate immune response without interference from the other vaccine.</span></li><li><span style=\"font-size:18px;\">Two live vaccines otherwise can be given together on the same day</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>General rules for multiple vaccine administration: \u2013</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">2 live vaccines can be given together</span></li><li><span style=\"font-size:18px;\">Live and killed vaccines can be given together</span></li><li><span style=\"font-size:18px;\">Cholera vaccine and Yellow fever vaccine cannot be given together</span></li><li><span style=\"font-size:18px;\">OPV is a live vaccine where single dose is not sufficient for immunization</span></li><li><span style=\"font-size:18px;\">2 live vaccines can be administered simultaneously at different sites (or at an interval of 4 weeks)</span></li></ul>",
    "correct_choice_id": 40583,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10221,
    "choices": [
      {
        "id": 40850,
        "text": "<p><span style=\"font-size:18px;\">Variance</span></p>"
      },
      {
        "id": 40851,
        "text": "<p><span style=\"font-size:18px;\">Coefficient of variation</span></p>"
      },
      {
        "id": 40852,
        "text": "<p><span style=\"font-size:18px;\">Standard error of mean</span></p>"
      },
      {
        "id": 40853,
        "text": "<p><span style=\"font-size:18px;\">Standard deviation</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>A comparison is made between the variability present in one dataset and that in another dataset by: </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q4967060",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175461,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Coefficient of variation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Coefficient of Variation (CV) is used to compare the relative variability of different datasets. It is a standardized measure of dispersion of a probability distribution or frequency distribution. The CV is particularly useful because it expresses the standard deviation as a percentage of the mean, making it possible to compare the degree of variation from one dataset to another, regardless of the unit of measurement or magnitude of the mean.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Co-efficient of Variation [COV] = SD/Mean x 100</span></li><li><span style=\"font-size:18px;\">It measures the relative variability by using the mean and standard deviation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Variance:&nbsp;</strong>Variance measures the spread of a set of numbers. It is the average of the squared differences from the mean. While it indicates variability, it does not provide a standardized measure for comparison between different datasets.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Standard Error of Mean (SEM):&nbsp;</strong>The SEM measures how much the sample mean of the data is likely to vary from the true population mean. It is used to understand the accuracy of the sample mean but is not used for comparing variability between datasets.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Standard Deviation (SD):&nbsp;</strong>Standard deviation is a measure of the amount of variation or dispersion in a set of values. While it indicates the spread of data points, it does not standardize this measure in relation to the mean, which is necessary for comparing different datasets.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Coefficient of Variation (CV) is the appropriate measure for comparing the relative variability of different datasets because it standardizes the measure of dispersion relative to the mean, allowing for meaningful comparisons across different datasets.</span></p>",
    "correct_choice_id": 40851,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57596,
    "choices": [
      {
        "id": 229753,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP can be done routinely after 24 weeks POG</span></p>"
      },
      {
        "id": 229754,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP is permissible for 20-24 weeks POG in this case</span></p>"
      },
      {
        "id": 229755,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP is permissible for 20-24 weeks POG in this case only if it threatens the life of the mother</span></p>"
      },
      {
        "id": 229756,
        "text": "<p><span style=\"font-size:12.0pt;\">MTP is permissible for 20-24 weeks POG in this case with 1 Doctor\u2019s opinion only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old woman presented to your hospital emergency with pregnancy 22 weeks, which was a result of rape. Correct statement regarding Medical Termination of Pregnancy is? (NEET PG 2024)</span></p>",
    "unique_key": "Q5642981",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175479,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) MTP is permissible for 20-24 weeks POG in this case</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the Medical Termination of Pregnancy (MTP) Act of India, MTP is permitted up to 24 weeks of pregnancy. For gestation periods from 0 to 20 weeks, it is considered low risk and only one doctor\u2019s opinion is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, for gestation periods from 20 to 24 weeks, it is categorized as high risk, and the approval of two doctors is required. This high-risk category includes specific situations such as <strong>rape, incest, disability, and when the woman is a minor</strong>. Since the woman in the question is 22 weeks pregnant due to rape, MTP is permissible under these regulations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. MTP can be done routinely after 24 weeks POG:</strong> This is incorrect because MTP after 24 weeks is not routinely allowed. It requires a medical board's approval and is only permitted in exceptional cases involving severe fetal anomalies or conditions that endanger the mother\u2019s life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. MTP is permissible for 20-24 weeks POG in this case only if it threatens the life of the mother:</strong> This statement is incorrect. For 20-24 weeks POG, MTP is permitted not only for life-threatening conditions but also for cases involving rape, incest, disability, and minors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. MTP is permissible for 20-24 weeks POG in this case with 1 Doctor\u2019s opinion only:</strong> This is incorrect because two doctors' opinions are required for high-risk cases between 20-24 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MTP between 20-24 weeks of pregnancy is considered high risk and requires two doctors' opinions, especially in cases of rape, incest, disability, or if the woman is a minor.</span></p>",
    "correct_choice_id": 229754,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 57598,
    "choices": [
      {
        "id": 229761,
        "text": "<p><span style=\"font-size:18px;\">Nothing should be given</span></p>"
      },
      {
        "id": 229762,
        "text": "<p><span style=\"font-size:18px;\">Penicillin</span></p>"
      },
      {
        "id": 229763,
        "text": "<p><span style=\"font-size:18px;\">Diphtheria antitoxin</span></p>"
      },
      {
        "id": 229764,
        "text": "<p><span style=\"font-size:18px;\">1 dose of DPT booster</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 5-year-old girl has a greyish white membrane over tonsils and presented with bull-neck appearance. She has a 2-year-old brother who is fully immunized for his age. What should be given to the brother? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q3774985",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175449,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Nothing should be given</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The 5-year-old girl shows clinical signs of diphtheria, characterized by a greyish white membrane over the tonsils and bull-neck appearance. The question asks about the appropriate management for her fully immunized 2-year-old brother, who is a close contact.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174329.jpg\" alt=\"\" width=\"400\" height=\"284\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>For contacts of a diphtheria case:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">If the contact (in this case, the brother) has received primary immunization or a booster within the last 2 years, no additional intervention is needed.</span></li><li><span style=\"font-size:18px;\">If the immunization or booster was taken more than 2 years ago, then a booster dose is required to maintain protection.</span></li><li><span style=\"font-size:18px;\">If the contact is completely unimmunized \u2013 Prophylactic t/t with Penicillin or Erythromycin along with 1000-2000 units Diphtheria antitoxin, and start immunization of contact</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Medical surveillance needs to be done daily and</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Bacteriological surveillance \u2013 swabs on weekly basis&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Since the brother is fully immunized for his age, and presumably within the past 2 years, no additional treatment is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Penicillin:&nbsp; </strong>This is used as prophylactic treatment for contacts who are completely unimmunized. It is not indicated for those who are fully vaccinated.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.&nbsp; Diphtheria antitoxin</strong>: This is administered to unimmunized contacts for immediate passive immunity, especially when there is a high risk of exposure, but it is not required for fully immunized individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.&nbsp; 1 dose of DPT booster:&nbsp;</strong> This is given if the last dose of primary immunization or booster was taken more than 2 years ago, but not needed if within the last 2 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In managing contacts of diphtheria, no additional doses are required if the contact has received primary immunization or booster within the last 2 years.</span></p>",
    "correct_choice_id": 229761,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57585,
    "choices": [
      {
        "id": 229709,
        "text": "<p><span style=\"font-size:18px;\">Transition from infectious pandemic diseases to man-made diseases</span></p>"
      },
      {
        "id": 229710,
        "text": "<p><span style=\"font-size:18px;\">Transition from low literacy levels to high literacy levels</span></p>"
      },
      {
        "id": 229711,
        "text": "<p><span style=\"font-size:18px;\">Transition from high birth rate &amp; death rate to low birth rate &amp; death rate</span></p>"
      },
      {
        "id": 229712,
        "text": "<p><span style=\"font-size:18px;\">Transition from unfavorable sex ratio to favorable sex ratio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>What is demographic transition as a country passes through the demographic cycle? </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q5900310",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175473,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Transition from high birth rate &amp; death rate to low birth rate &amp; death rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173804.jpg\" alt=\"\" width=\"400\" height=\"340\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The demographic transition refers to the shift in a country\u2019s population characteristics as it moves through different stages of the demographic cycle. The cycle typically includes five stages, starting with high birth and death rates (Stage 1), followed by declining death rates (Stage 2), declining birth rates (Stage 3), and eventually both low birth and death rates (Stage 4). This process reflects changes in a society\u2019s economic and social conditions, such as improvements in healthcare, education, and overall living standards. The transition leads to slower population growth and ultimately stabilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Transition from infectious pandemic diseases to man-made diseases:</strong> This option describes the <strong>epidemiological transition</strong>, which refers to the shift in the types of prevalent diseases from infectious to chronic, non-communicable diseases as a society develops.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Transition from low literacy levels to high literacy levels:</strong> This option reflects educational and social changes within a population but does not specifically describe demographic transition.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Transition from unfavorable sex ratio to favorable sex ratio:</strong> This option describes changes in gender ratios, often due to social or policy influences, but it is not directly related to demographic transition.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Demographic transition is characterized by the shift from high birth and death rates to low birth and death rates as a country progresses through the stages of the demographic cycle.</span></p>",
    "correct_choice_id": 229711,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10186,
    "choices": [
      {
        "id": 40710,
        "text": "<p><span style=\"font-size:18px;\">First come first treated basis</span></p>"
      },
      {
        "id": 40711,
        "text": "<p><span style=\"font-size:18px;\">Green labels are for those who need to be transported on priority</span></p>"
      },
      {
        "id": 40712,
        "text": "<p><span style=\"font-size:18px;\">Moribund patients receive the lowest priority</span></p>"
      },
      {
        "id": 40713,
        "text": "<p><span style=\"font-size:18px;\">Most commonly used system is three color code system</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>During disaster management, triage is conducted to ensure proper treatment of casualties. What are the accurate aspects of the triage process carried out at the site of the disaster? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q9418663",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175452,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Moribund patients receive the lowest priority</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In Triage, these patients are given different color coding as mentioned below \u2013</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125428.jpg\" alt=\"\" width=\"700\" height=\"286\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In disaster triage, moribund patients receive the lowest priority, allowing medical resources to be focused on patients with a higher chance of survival.</span></p>",
    "correct_choice_id": 40712,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 57589,
    "choices": [
      {
        "id": 229725,
        "text": "<p><span style=\"font-size:18px;\">Nitrate test</span></p>"
      },
      {
        "id": 229726,
        "text": "<p><span style=\"font-size:18px;\">Phosphatase test</span></p>"
      },
      {
        "id": 229727,
        "text": "<p><span style=\"font-size:18px;\">Paper chromatography test</span></p>"
      },
      {
        "id": 229728,
        "text": "<p><span style=\"font-size:18px;\">Sulphuric acid test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A lot of patients presented to PHC OPD with edema, ocular problems, cardiac failure. Several deaths were reported too. There was a common history of buying oil from a local grocery store. Drug inspector will use the following test to detect adulteration. </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q2663215",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175477,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Paper chromatography test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The condition described in the question is <strong>epidemic dropsy</strong>, which is caused by the consumption of <strong>mustard oil adulterated with Argemone Mexicana oil.</strong> The toxic component of Argemone oil is <strong>Sanguinarine</strong>, a potent toxin that inhibits the oxidation of pyruvic acid, leading to symptoms such as <strong>bilateral non-inflammatory edema, glaucoma, congestive heart failure, and even death.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Paper chromatography test</strong> is the most sensitive method to detect Argemone oil adulteration in mustard oil, even at extremely low concentrations (0.0001%). This test identifies the presence of Sanguinarine, thus confirming the contamination of the mustard oil with Argemone oil.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Other test is - Nitric acid test shows an orange-brown discoloration if Argemone oil is present, requiring a concentration of 0.25% for a positive result.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Nitrate test: </strong>This option is incorrect. The nitrate test is commonly employed to detect nitrates in water, food, or soil.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Phosphatase test:&nbsp; </strong>This option is incorrect. The phosphatase test is used primarily to determine the pasteurization status of milk, not for detecting oil adulteration.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Sulphuric acid test: </strong>This option is incorrect. While sulphuric acid can be used in various tests, it is not the specific test for detecting Argemone oil adulteration in mustard oil.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Epidemic dropsy is caused by the consumption of mustard oil adulterated with Argemone Mexicana oil, and the most sensitive test for detecting this adulteration is the paper chromatography test.</span></p>",
    "correct_choice_id": 229727,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10153,
    "choices": [
      {
        "id": 40578,
        "text": "<p><span style=\"font-size:18px;\">Vertical transmission</span></p>"
      },
      {
        "id": 40579,
        "text": "<p><span style=\"font-size:18px;\">Contact with soil</span></p>"
      },
      {
        "id": 40580,
        "text": "<p><span style=\"font-size:18px;\">Droplet nuclei</span></p>"
      },
      {
        "id": 40581,
        "text": "<p><span style=\"font-size:18px;\">Droplet transmission</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which of these options is not a means of directly transmitting communicable diseases? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
    "unique_key": "Q2646277",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175447,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Droplet nuclei</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Airborne transmission by droplet nuclei is a method of indirect transmission of diseases.</span></li><li><span style=\"font-size:18px;\">Droplet nuclei are tiny particles of size 1-5 microns range that may be formed by either due to evaporation of droplets coughed or sneezed into the air or are formed from aerosols.</span></li><li><span style=\"font-size:18px;\">These droplet nuclei remain airborne for long periods of time and can transmit diseases like tuberculosis, influenza, chickenpox, measles, Q fever and other respiratory infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Direct Transmission Methods:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Vertical transmission:&nbsp;</strong>This occurs when infections are passed from mother to child during pregnancy, childbirth, or breastfeeding. Examples include HIV and congenital syphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Contact with soil (B):&nbsp;</strong>Direct contact with contaminated soil can lead to infections. Soil-transmitted helminths and diseases like tetanus are examples.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Droplet transmission:&nbsp;</strong>This involves large respiratory droplets (typically greater than 5 microns) that are expelled when an infected person coughs, sneezes, or talks. These droplets can travel short distances and infect individuals through mucosal surfaces (e.g., eyes, nose, mouth). Examples include the common cold, influenza, and COVID-19.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Droplet nuclei&nbsp;</strong>represent an <strong>indirect transmission</strong> method, as they can remain airborne for long periods and travel over distances, whereas <strong>vertical transmission</strong>, <strong>contact with soil</strong>, and <strong>droplet transmission</strong> are forms of <strong>direct transmission</strong> of communicable diseases.</span></p>",
    "correct_choice_id": 40580,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 10879,
    "choices": [
      {
        "id": 43482,
        "text": "<p><span style=\"font-size:12.0pt;\">Secondary attack rate</span></p>"
      },
      {
        "id": 43483,
        "text": "<p><span style=\"font-size:12.0pt;\">Serial interval</span></p>"
      },
      {
        "id": 43484,
        "text": "<p><span style=\"font-size:12.0pt;\">Incubation period</span></p>"
      },
      {
        "id": 43485,
        "text": "<p><span style=\"font-size:12.0pt;\">Case fatality rate</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A researcher is studying the spread of a new viral illness. He wants to determine the probability that a susceptible person will contract the disease after close contact with an infected person. Which measure best describes this probability? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q2960824",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175457,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Secondary attack rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The secondary attack rate (SAR) measures the probability that a susceptible individual will contract the disease after coming into close contact with an infected individual. It is a useful measure for gauging the infectious potential of an agent within a population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Infectivity is known by calculating the secondary attack rates.</span></p><p><br><span style=\"font-size:12.0pt;\">SAR = (Total no. of secondary cases * 100) / (Total susceptible population-primary cases)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Serial interval</strong> is the average time difference between the primary and secondary case, which is similar to the median incubation period</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Incubation period</strong>: Entry of organism in the human body till the first sign / symptom is produced.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The Case fatality rate</strong> = (Number of deaths due to a disease / number of cases of that particular disease) * 100</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Case fatality rate typically is used as a measure of disease severity and is often used for prognosis. Always expressed in %. CFR of Rabies is 100%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The secondary attack rate (SAR) is a critical measure for assessing the infectious potential of a disease, indicating the likelihood that a disease will spread among susceptible individuals after exposure to an infected person.</span></p>",
    "correct_choice_id": 43482,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 57595,
    "choices": [
      {
        "id": 229749,
        "text": "<p><span style=\"font-size:18px;\">Integrated Disease Surveillance Program</span></p>"
      },
      {
        "id": 229750,
        "text": "<p><span style=\"font-size:18px;\">National TB Elimination Program</span></p>"
      },
      {
        "id": 229751,
        "text": "<p><span style=\"font-size:18px;\">National Leprosy Eradication Program</span></p>"
      },
      {
        "id": 229752,
        "text": "<p><span style=\"font-size:18px;\">National Health Mission</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>The given image is the logo for which of the following health programs? </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174045.jpg\" alt=\"\" width=\"400\" height=\"487\"></strong></span></p>",
    "unique_key": "Q8329922",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175481,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) National Leprosy Eradication Program</strong></span></p><p><br><span style=\"font-size:18px;\">The logo shown is for the National Leprosy Eradication Program (NLEP). The design of the logo holds significant meaning:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Sun:</strong> The sun in the center of the hand symbolizes hope and optimism, reflecting the positive outcomes of leprosy treatment.</span></li><li><span style=\"font-size:18px;\"><strong>Lotus Flower:</strong> This represents purity and beauty, indicating that there should be no stigma attached to those affected by leprosy.</span></li><li><span style=\"font-size:18px;\"><strong>Cured Thumb:</strong> The image of the healed thumb symbolizes that leprosy is a 100% curable disease. The thumb indicates that the affected person has been cured and is now a fully integrated member of society.</span></li><li><span style=\"font-size:18px;\"><strong>House-Shaped Hand:</strong> The hand shaped like a house emphasizes that the cured individual is an integral part of their family and community.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">These elements collectively reinforce the message of hope, inclusion, and the need to remove stigma associated with leprosy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Integrated Disease Surveillance Program (logo):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174128.jpg\" alt=\"\" width=\"400\" height=\"375\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.&nbsp; National TB Elimination Program (logo):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174151.jpg\" alt=\"\" width=\"300\" height=\"368\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.&nbsp; National Health Mission (logo):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174218.jpg\" alt=\"\" width=\"300\" height=\"244\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">The National Leprosy Eradication Program logo symbolizes hope, the curability of leprosy, and the inclusion of cured individuals into society, promoting a stigma-free approach towards the disease.</span></p>",
    "correct_choice_id": 229751,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10217,
    "choices": [
      {
        "id": 40834,
        "text": "<p><span style=\"font-size:18px;\">&lt;70</span></p>"
      },
      {
        "id": 40835,
        "text": "<p><span style=\"font-size:18px;\">&lt;100</span></p>"
      },
      {
        "id": 40836,
        "text": "<p><span style=\"font-size:18px;\">&lt;50</span></p>"
      },
      {
        "id": 40837,
        "text": "<p><span style=\"font-size:18px;\">&lt;130</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Within the framework of Sustainable Development Goal 3, the objective of target 3.1 is to achieve a reduction in the Maternal Mortality Ratio to what specific level (per 1 lakh live birts) by the year 2030? </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q6130945",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175467,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) &lt;70</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In Sustainable Development Goal 3, the target 3.1 aims to reduce the Maternal Mortality Ratio by 2030 to &lt;70 per 1 lakh live births.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173901.jpg\" alt=\"\" width=\"716\" height=\"442\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>SDGs \u2013 Targets &amp; Indicators</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">3.1 - By 2030, MMR &lt; 70</span></p><p><span style=\"font-size:18px;\">3.2 - By 2030, NNMR 12 &amp; U5MR 25</span></p><p><span style=\"font-size:18px;\">3.3 - By 2030, end epidemics of AIDS, TB, Malaria and NTDs and combat Hepatitis, Water-borne diseases and other CDS.</span></p><p><span style=\"font-size:18px;\">3.4 - By 2030, reduce by 1/3 premature mortality from NCDs.</span></p><p><span style=\"font-size:18px;\">3.5 - Strengthen the prevention &amp; treatment of substance abuse.</span></p><p><span style=\"font-size:18px;\">3.6 - By 2020, halve the global deaths and injuries form RTA.</span></p><p><span style=\"font-size:18px;\">3.7 - By 2030, universal access to Sexual &amp; Rep \u2013 health care services.</span></p><p><span style=\"font-size:18px;\">3.8 - Achieve Universal health coverage.</span></p><p><span style=\"font-size:18px;\">3.9 - By 2030, reduce the number of deaths, illnesses form hazardous chemicals and air, water and soil pollution and contamination.</span></p>",
    "correct_choice_id": 40834,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 44304,
    "choices": [
      {
        "id": 176867,
        "text": "<p><span style=\"font-size:12.0pt;\">IUCD</span></p>"
      },
      {
        "id": 176868,
        "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
      },
      {
        "id": 176869,
        "text": "<p><span style=\"font-size:12.0pt;\">LNG</span></p>"
      },
      {
        "id": 176870,
        "text": "<p><span style=\"font-size:12.0pt;\">OCP</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female presented to the OPD within 5 days of unprotected sexual intercourse. Which contraception is advised? (FMGE JANUARY 2024)</span></p>",
    "unique_key": "Q7391147",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175440,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IUCD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a female presenting within 5 days of unprotected sexual intercourse, the most effective emergency contraceptive (interceptive) method advised is the intrauterine contraceptive device (IUCD).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The IUCD is the recommended method of choice for emergency contraception with the highest efficacy and least failure rate when used within 5 days of unprotected intercourse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>B. Misoprostol:</strong> This option is incorrect because misoprostol is not an emergency contraceptive method.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>C. LNG:</strong> Levonorgestrel (LNG) is a widely accepted method of emergency contraception and is recommended as a first-line option. However, its effectiveness is optimal only within 72 hours of unprotected intercourse, with significantly reduced efficacy beyond this timeframe. And an intrauterine contraceptive device (IUCD) remains the most effective alternative, providing protection for up to 5 days post-intercourse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>D. OCP:</strong> This option is incorrect. While combined oral contraceptive pills (OCPs) are an option, they are not the recommended method of choice when the female presents within 5 days of unprotected intercourse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The recommended emergency contraceptive method currently in use are \u2013</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">OCPs (Yuzpe and Lancee Method) \u2013&nbsp; (pills with 30 mcg oestrogen) - 4 pills immediately followed by 4 pills 12 hours later. This method can be used till 72hrs of intercourse.</span></li><li><span style=\"font-size:12.0pt;\">Mini Pills (POP): Progesterone only Pill (POP) 0.75 mg \u2013 Pill has to be \u2018used within 72 hours of intercourse (LNG oral tablet (0.75 mg): 1st tablet within 72 hours of intercourse and 2nd tablet after 12 hours of first dose)</span></li><li><span style=\"font-size:12.0pt;\"><strong>IUCD (most effective; highest efficacy &amp; least failure) \u2013 can be used till 5 days</strong></span></li><li><span style=\"font-size:12.0pt;\">RU486 (mifepristone) \u2013 within 72 hours</span></li><li><span style=\"font-size:12.0pt;\">High dose of estrogen \u2013 to be continuously used for 5 days</span></li></ul>",
    "correct_choice_id": 176867,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 10882,
    "choices": [
      {
        "id": 43494,
        "text": "<p><span style=\"font-size:12.0pt;\">Women education and empowerment</span></p>"
      },
      {
        "id": 43495,
        "text": "<p><span style=\"font-size:12.0pt;\">Children and new-born care.</span></p>"
      },
      {
        "id": 43496,
        "text": "<p><span style=\"font-size:12.0pt;\">Screening and treatment for STI and RTI</span></p>"
      },
      {
        "id": 43497,
        "text": "<p><span style=\"font-size:12.0pt;\">Safe motherhood</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT typically recognized as a primary component of the RCH program? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q2260932",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175433,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Women education and empowerment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While education and empowerment of women are crucial for overall health improvement, they are not specifically listed as a primary component of the RCH program.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Reproductive and Child Health (RCH) program focuses on specific health services to improve the health of mothers and children. The primary components of the RCH program include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Children and newborn care:</strong> Services aimed at ensuring the health and well-being of children and newborns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Screening and treatment for STI and RTI:</strong> Control and prevention of reproductive tract infections (RTI) and sexually transmitted infections (STI).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Safe motherhood:</strong> Initiatives to ensure the health and safety of mothers during pregnancy, childbirth, and the postpartum period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Component of RCH program -&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Community Needs Assessment Approach (CNAA)</span></li><li><span style=\"font-size:12.0pt;\">Integrated packages of services for mother and child</span></li><li><span style=\"font-size:12.0pt;\">MTP services at PHC and safe abortion</span></li><li><span style=\"font-size:12.0pt;\">Control and prevention of RTI/STI</span></li><li><span style=\"font-size:12.0pt;\">Adolescent health</span></li><li><span style=\"font-size:12.0pt;\">Services in urban slums</span></li><li><span style=\"font-size:12.0pt;\">Improving quality of services</span></li><li><span style=\"font-size:12.0pt;\">Unmet needs and sub-centre action plans</span></li><li><span style=\"font-size:12.0pt;\">Communication strategy</span></li><li><span style=\"font-size:12.0pt;\">Gender sensitiveness</span></li><li><span style=\"font-size:12.0pt;\">Greater involvement of Panchayati Raj Institutions (PRIs), NGOs and community</span></li></ul>",
    "correct_choice_id": 43494,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10876,
    "choices": [
      {
        "id": 43470,
        "text": "<p><span style=\"font-size:12.0pt;\">Td dose 0,3</span></p>"
      },
      {
        "id": 43471,
        "text": "<p><span style=\"font-size:12.0pt;\">Tt booster dose</span></p>"
      },
      {
        "id": 43472,
        "text": "<p><span style=\"font-size:12.0pt;\">Td booster dose</span></p>"
      },
      {
        "id": 43473,
        "text": "<p><span style=\"font-size:12.0pt;\">Tt dose 0</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 27-year-old pregnant woman in her second trimester has a 2-year-old child. She received a complete vaccination course during her last pregnancy. What tetanus immunization is recommended for her now? (FMGE JAN 2023)</span></p>",
    "unique_key": "Q6060713",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175482,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Td booster dose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per National Immunization Schedule, the recommendations for pregnant woman are as follows: -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Td-1: Early in pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Td-2: 4 weeks after Td-1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Td-Booster dose: if pregnancy occurs within 3 years of last pregnancy and 2 Td doses were received.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For pregnant women who received the complete Td vaccination course during their last pregnancy within the last three years, a Td booster dose is recommended.</span></p>",
    "correct_choice_id": 43472,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 57600,
    "choices": [
      {
        "id": 229769,
        "text": "<p><span style=\"font-size:18px;\">Crude birth rate \u2013 Crude death rate</span></p>"
      },
      {
        "id": 229770,
        "text": "<p><span style=\"font-size:18px;\">Crude birth rate + Crude death rate</span></p>"
      },
      {
        "id": 229771,
        "text": "<p><span style=\"font-size:18px;\">Crude birth rate / Crude death rate</span></p>"
      },
      {
        "id": 229772,
        "text": "<p><span style=\"font-size:18px;\">Crude birth rate \u00d7 Crude death rate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>What is Demographic gap?</strong><i><strong> [NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q6989351",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175434,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Crude birth rate \u2013 Crude death rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The demographic gap refers to the difference between the crude birth rate and the crude death rate. It essentially measures the net increase in the population, referred to as the <strong>growth rate.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In demographic terms:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">A positive demographic gap indicates that the birth rate is higher than the death rate, leading to population growth.</span></li><li><span style=\"font-size:18px;\">A negative demographic gap indicates a declining population when the death rate exceeds the birth rate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">The demographic gap is minimal during the early and late stages of the demographic transition model (Stages 1 and 4), where birth and death rates are balanced or declining. It peaks during Stage 2 when the birth rate remains high but the death rate drops significantly. In Stage 3, the gap starts to contract as birth rates begin to fall, and in Stage 5, it can become negative as populations age and birth rates fall below death rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The demographic gap is defined as the difference between the crude birth rate and the crude death rate, representing the population growth rate</span></p>",
    "correct_choice_id": 229769,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 10149,
    "choices": [
      {
        "id": 40562,
        "text": "<p><span style=\"font-size:18px;\">90/100</span></p>"
      },
      {
        "id": 40563,
        "text": "<p><span style=\"font-size:18px;\">100/110</span></p>"
      },
      {
        "id": 40564,
        "text": "<p><span style=\"font-size:18px;\">(90-10)/1000</span></p>"
      },
      {
        "id": 40565,
        "text": "<p><span style=\"font-size:18px;\">90/1000</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>In a screening examination conducted on a population of 1000 individuals for diabetes mellitus (DM), 90 individuals tested positive. Subsequently, a gold standard test for DM was performed, identifying 100 positive cases. What is the calculated sensitivity? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
    "unique_key": "Q1347427",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175443,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) 90/100</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In given question, the following data are provided:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total population = 1000</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total diseased people = 100 (identified by gold standard test)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Total number of diabetics identified initially = 90, thus</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">total positive identified by screening test =90</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-092605.png\" alt=\"\" width=\"1000\" height=\"216\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Therefore:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sensitivity = TP/(TP+FN) =90/ (90+10) = 90/100 = 90%</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Sensitivity is the proportion of true positive cases correctly identified by a screening test out of all actual positive cases identified by the gold standard test.</span></p>",
    "correct_choice_id": 40562,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 46445,
    "choices": [
      {
        "id": 185399,
        "text": "<p><span style=\"font-size:12.0pt;\">Single exposure, point source epidemic</span></p>"
      },
      {
        "id": 185400,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple exposure, point source epidemic</span></p>"
      },
      {
        "id": 185401,
        "text": "<p><span style=\"font-size:12.0pt;\">Propagated epidemic</span></p>"
      },
      {
        "id": 185402,
        "text": "<p><span style=\"font-size:12.0pt;\">Common intermittent source epidemic</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the type of epidemic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-125643.jpg\" alt=\"\" width=\"300\" height=\"113\"></span></p>",
    "unique_key": "Q4119083",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175469,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Common intermittent source epidemic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The graph shows cases occurring at irregular intervals with gaps between them, indicating that people are exposed intermittently to the source of infection. This pattern is characteristic of a <strong>common intermittent source epidemic</strong>, where exposures occur sporadically, leading to multiple peaks over time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A. Single exposure, point source epidemic:</strong> Characterized by a sudden rise and fall in the number of cases within a single incubation period, showing a single peak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-125740.jpg\" alt=\"\" width=\"400\" height=\"283\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options B. Multiple exposure, point source epidemic:</strong> Shows multiple peaks due to repeated exposures, but the rise and fall are not as sudden and are marked by secondary waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-125818.jpg\" alt=\"\" width=\"400\" height=\"242\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options C. Propagated epidemic:</strong> Involves person-to-person transmission, typically showing a slow rise, a plateau, and a slow fall in the number of cases over time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/30/screenshot-2024-05-30-125837.jpg\" alt=\"\" width=\"400\" height=\"187\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A common intermittent source epidemic is marked by cases appearing at irregular intervals, reflecting intermittent exposures to the source of infection.</span></p>",
    "correct_choice_id": 185402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "ImageBased"
    ]
  },
  {
    "id": 10212,
    "choices": [
      {
        "id": 40814,
        "text": "<p><span style=\"font-size:18px;\">Cardiovascular diseases</span></p>"
      },
      {
        "id": 40815,
        "text": "<p><span style=\"font-size:18px;\">Cervical Cancer</span></p>"
      },
      {
        "id": 40816,
        "text": "<p><span style=\"font-size:18px;\">Breast Cancer</span></p>"
      },
      {
        "id": 40817,
        "text": "<p><span style=\"font-size:18px;\">Road Traffic Accidents</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>The scope of Project MONICA includes: </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q6338313",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175463,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Cardiovascular diseases&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Project MONICA is related to cardiovascular diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The WHO MONICA (<strong>MONI</strong>toring trends and determinants in <strong>CA</strong>rdiovascular disease) Project was designed to measure trends and determinants in cardiovascular disease mortality and coronary heart disease and cerebrovascular disease morbidity, and to assess the extent to which these trends are related to changes in known risk factors in different populations in 27 countries (10 years\u2019 period)</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The scope of Project MONICA is focused on cardiovascular diseases, specifically monitoring trends in coronary heart disease and cerebrovascular disease and examining the impact of various risk factors on these conditions.</span></p>",
    "correct_choice_id": 40814,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 46451,
    "choices": [
      {
        "id": 185423,
        "text": "<p><span style=\"font-size:12.0pt;\">Blood sugar</span></p>"
      },
      {
        "id": 185424,
        "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure</span></p>"
      },
      {
        "id": 185425,
        "text": "<p><span style=\"font-size:12.0pt;\">Blood grouping</span></p>"
      },
      {
        "id": 185426,
        "text": "<p><span style=\"font-size:12.0pt;\">Blood lipids</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Not included in STEPS approach for Non-communicable diseases is (FMGE JULY 2023)</span></p>",
    "unique_key": "Q5662869",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175476,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Blood grouping</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The WHO STEPS approach for <strong>non-communicable disease (NCD) risk factor &amp; STROKE surveillance</strong> involves three steps: behavioral measurements, physical measurements, and biochemical measurements. These steps focus on key indicators related to NCDs and stroke surveillance.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>The specific indicators include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Step 1: Behavioral measurements</strong> \u2013 (for both core &amp; expanded indicators) Tobacco use, alcohol consumption, diet, exercise, history of raised blood pressure, and diabetes mellitus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Step 2: Physical measurements</strong> - Core indicators include height, weight, waist circumference, and blood pressure; expanded indicators include hip circumference and heart rate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Step 3: Biochemical measurements</strong> - Core indicators include blood glucose and blood lipids; expanded indicators include triglycerides and serum cholesterol levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blood grouping is not a part of the STEPS approach as it does not relate to the risk factors or measurements for NCDs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Blood sugar:</strong> Included as a core biochemical measurement (blood glucose).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Blood pressure:</strong> Included as a core physical measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Blood lipids:</strong> Included as a core biochemical measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO STEPS approach for NCD risk factor surveillance includes behavioral, physical, and biochemical measurements, but blood grouping is not included in these indicators.</span></p>",
    "correct_choice_id": 185425,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 57583,
    "choices": [
      {
        "id": 229701,
        "text": "<p><span style=\"font-size:18px;\">75</span></p>"
      },
      {
        "id": 229702,
        "text": "<p><span style=\"font-size:18px;\">100</span></p>"
      },
      {
        "id": 229703,
        "text": "<p><span style=\"font-size:18px;\">125</span></p>"
      },
      {
        "id": 229704,
        "text": "<p><span style=\"font-size:18px;\">150</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>There were 4000 live births in a community in a year. Do MMR Calculation if you come to know that 6 women died during pregnancy, labor/delivery, or within 42 days of delivery - 2 due to Obstructed labor, 1 due to Sepsis, 1 due to PPH, 1 due to Snake bite and 1 due to electrocution.</strong><i><strong> [NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q3256441",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175471,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) 100</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Maternal Mortality Ratio (MMR) is calculated using the formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173703.jpg\" alt=\"\" width=\"700\" height=\"143\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In this scenario, there were 4000 live births in the community.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Calculation of Maternal Deaths:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Maternal death is defined as the death of a woman during pregnancy, labor, or within 42 days of termination of pregnancy, provided the death is related to maternity or its complications.</span></li><li><span style=\"font-size:18px;\">Out of the 6 reported deaths:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">2 deaths due to Obstructed labor (included)</span></li><li><span style=\"font-size:18px;\">1 death due to Sepsis (included)</span></li><li><span style=\"font-size:18px;\">1 death due to PPH (Postpartum Hemorrhage) (included)</span></li><li><span style=\"font-size:18px;\">1 death due to Snake bite (not related to maternity, hence excluded)</span></li><li><span style=\"font-size:18px;\">1 death due to Electrocution (not related to maternity, hence excluded)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Therefore, only 4 deaths are considered maternal deaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Substituting in the formula:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-173720.jpg\" alt=\"\" width=\"700\" height=\"154\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Maternal Mortality Ratio (MMR) is calculated as the number of maternal deaths per 100,000 live births, considering only deaths directly related to pregnancy or its complications.</span></p>",
    "correct_choice_id": 229702,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 46427,
    "choices": [
      {
        "id": 185327,
        "text": "<p><span style=\"font-size:12.0pt;\">Objective</span></p>"
      },
      {
        "id": 185328,
        "text": "<p><span style=\"font-size:12.0pt;\">Target</span></p>"
      },
      {
        "id": 185329,
        "text": "<p><span style=\"font-size:12.0pt;\">Goal</span></p>"
      },
      {
        "id": 185330,
        "text": "<p><span style=\"font-size:12.0pt;\">Principle</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not constrained by time? (FMGE JULY 2023)</span></p>",
    "unique_key": "Q4005643",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175459,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Goal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A goal is <strong>the ultimate desired state</strong> that a health program aims to achieve. It is not constrained by time, meaning that a goal does <strong>not have a specific timeline</strong> associated with it. Additionally, a goal is <strong>not necessarily attainable</strong>, as it represents the ultimate desired outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Objective:&nbsp;</strong> An objective is a <strong>specific, planned activity</strong> in a health program. Objectives are designed to help achieve the goal and are usually associated with a <strong>timeline</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Target:&nbsp;</strong> A target is the <strong>degree of achievement</strong> of objectives and is always associated with a <strong>timeline.</strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Principle:&nbsp;</strong> The principles are generally <strong>guidelines or fundamental truths</strong> and do not specify timelines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of health programs, a goal is the ultimate desired state and is not constrained by time or resources. It represents an \"<strong>all or none\" phenomenon</strong> and may not always be attainable.</span></p>",
    "correct_choice_id": 185329,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 44303,
    "choices": [
      {
        "id": 176863,
        "text": "<p><span style=\"font-size:12.0pt;\">1 doctor</span></p>"
      },
      {
        "id": 176864,
        "text": "<p><span style=\"font-size:12.0pt;\">2 doctors</span></p>"
      },
      {
        "id": 176865,
        "text": "<p><span style=\"font-size:12.0pt;\">Court</span></p>"
      },
      {
        "id": 176866,
        "text": "<p><span style=\"font-size:12.0pt;\">Medical board</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Medical termination of pregnancy at 22 weeks of gestation for contraceptive failure after 21 weeks requires approval from:&nbsp;</span>&nbsp;(FMGE JANUARY 2024)</p>",
    "unique_key": "Q7204241",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175439,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2 doctors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Now, MTP is permitted till 24 weeks of gestation. It is divided into two categories: low-risk MTP and high-risk MTP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Low-risk MTP</strong>: performed up to 20 weeks of gestation, requires the approval of only one doctor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>High-risk MTP</strong>: includes cases where the gestational age is between 20 weeks to 24 weeks, the approval of two doctors is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The specifies that the MTP is being considered at 22 weeks of gestation, which falls under the high-risk category. Therefore, the approval of two doctors is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>A. 1 doctor:</strong> This option is incorrect because gestational ages above 20 weeks and up to 24 weeks, the approval of two doctors is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>C. Court:</strong> This option is incorrect because court approval is not required for MTP up to 24 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong> <strong>D. Medical board:</strong> This option is incorrect because a medical board's approval is only required for cases involving severe fetal malformations after 24 weeks of gestation, not for the scenario described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For medical termination of pregnancy between 20 and 24 weeks of gestation, which is considered a high-risk category, the approval of two doctors is required.</span></p>",
    "correct_choice_id": 176864,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 44315,
    "choices": [
      {
        "id": 176911,
        "text": "<p><span style=\"font-size:12.0pt;\">Every Day</span></p>"
      },
      {
        "id": 176912,
        "text": "<p><span style=\"font-size:12.0pt;\">Every week</span></p>"
      },
      {
        "id": 176913,
        "text": "<p><span style=\"font-size:12.0pt;\">Every 14 days</span></p>"
      },
      {
        "id": 176914,
        "text": "<p><span style=\"font-size:12.0pt;\">Every Month</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Rukmani is attending a Village Nutrition and Sanitation Programme. How frequently is it conducted? (</span>FMGE Jan 2024)</p>",
    "unique_key": "Q1150536",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175442,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Every month</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Village Health Sanitation and Nutrition Committee organizes a Village Health Sanitation and Nutrition Day once every month.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rukmani is attending a \"Village Nutrition and Sanitation Programme,\" which is likely referring to the Village Health Sanitation and Nutrition Day organized by the committee.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Village Health Sanitation and Nutrition Programme, which Rukmani is attending, is conducted once every month by the Village Health Sanitation and Nutrition Committee.</span></p>",
    "correct_choice_id": 176914,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10191,
    "choices": [
      {
        "id": 40730,
        "text": "<p><span style=\"font-size:18px;\">Line graph</span></p>"
      },
      {
        "id": 40731,
        "text": "<p><span style=\"font-size:18px;\">Histogram</span></p>"
      },
      {
        "id": 40732,
        "text": "<p><span style=\"font-size:18px;\">Ogive</span></p>"
      },
      {
        "id": 40733,
        "text": "<p><span style=\"font-size:18px;\">Stem and leaf plot</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What method is most effective for visually representing the fluctuations in disease occurrence within a given area over time? </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
    "unique_key": "Q8647703",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175458,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Line graph</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Line graphs or line diagrams are the best way to plot the changes in the incidence of a disease in a given area over time (TREND of any event).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/65.jpg\" alt=\"\" width=\"500\" height=\"266\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong> <strong>Histogram: </strong>Is graphical presentation for \u2018continuous quantitative data\u2019</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Continuous groups are marked on x-axis (abscissa) while frequencies are marked on y-axis (ordinate).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125430.jpg\" alt=\"\" width=\"500\" height=\"379\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Ogive:&nbsp;</strong> Is graph of cumulative relative frequency distribution</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125431.jpg\" alt=\"\" width=\"500\" height=\"254\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Stem and leaf plot:&nbsp;</strong> Represents quantitative data in graphical format which helps us visualize the shape of distribution. We are able to represent frequencies for different classes of values.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/whatsapp-image-2023-10-03-at-123902.jpeg\" alt=\"\" width=\"500\" height=\"227\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Line graphs are the most effective method for visually representing the fluctuations in disease occurrence over time, making them ideal for identifying and analyzing trends in epidemiological data.</span></p>",
    "correct_choice_id": 40730,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 57586,
    "choices": [
      {
        "id": 229713,
        "text": "<p><span style=\"font-size:18px;\">Blood culture</span></p>"
      },
      {
        "id": 229714,
        "text": "<p><span style=\"font-size:18px;\">Widal test</span></p>"
      },
      {
        "id": 229715,
        "text": "<p><span style=\"font-size:18px;\">Stool culture</span></p>"
      },
      {
        "id": 229716,
        "text": "<p><span style=\"font-size:18px;\">Urine culture</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 30-year-old male travels frequently and has food during his travels. He presents to PHC OPD with abdominal pain, fever for 4 days. He has bradycardia too. Test for confirmation of diagnosis: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q7158253",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175475,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;(a) Blood culture</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The clinical presentation suggests a diagnosis of enteric fever (typhoid), characterized by abdominal pain, fever, and bradycardia. The appropriate diagnostic test depends on the stage of the illness:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Blood culture</strong> is the test of choice from the first week of illness onwards. It remains the most reliable test in the initial stages (within the first week of symptoms) to confirm typhoid fever. This test directly detects the presence of Salmonella bacteria in the blood, making it the most accurate diagnostic method during early illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Widal test</strong>: This serological test detects antibodies against Salmonella and is typically used from the second week of illness onwards. It is not the preferred test during the first week as antibodies may not yet be present in detectable quantities.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Stool culture</strong>: This is used from the third week of illness onwards and detects Salmonella in the gastrointestinal tract. It is not suitable for early diagnosis as it becomes positive later in the disease course.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Urine culture</strong>: This is used from the fourth week of illness onwards. It detects Salmonella excreted in the urine, but like stool culture, it is useful later in the course of the disease and not for initial diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">For typhoid fever diagnosis in the first week of illness, <strong>blood culture</strong> is the most appropriate and reliable test.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Mnemonic \u2013 BASU</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Blood culture \u2013 1<sup>st</sup> week onwards</span></p><p><span style=\"font-size:18px;\">Antibody test (Widal) \u2013 2<sup>nd</sup> week onwards</span></p><p><span style=\"font-size:18px;\">Stool culture \u2013 3<sup>rd</sup> week onwards</span></p><p><span style=\"font-size:18px;\">Urine culture \u2013 4<sup>th</sup> week onwards</span></p>",
    "correct_choice_id": 229713,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG"
    ]
  },
  {
    "id": 57584,
    "choices": [
      {
        "id": 229705,
        "text": "<p><span style=\"font-size:18px;\">Monovalent with 1 dose</span></p>"
      },
      {
        "id": 229706,
        "text": "<p><span style=\"font-size:18px;\">Monovalent with 2 doses</span></p>"
      },
      {
        "id": 229707,
        "text": "<p><span style=\"font-size:18px;\">Bivalent with 1 dose</span></p>"
      },
      {
        "id": 229708,
        "text": "<p><span style=\"font-size:18px;\">Bivalent with 2 doses</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>True regarding Oral Cholera vaccine \u2018Sanchol\u2019 is: </strong><i><strong>[NEET PG 2024]</strong></i></span></p>",
    "unique_key": "Q2366169",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175472,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans.&nbsp;(d) Bivalent with 2 doses</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The oral cholera vaccine \u2018Sanchol\u2019 is a bivalent vaccine designed to protect against serotypes O1 and O139 of the cholera bacteria. It is administered as 2 liquid doses for individuals aged 1 year and older, with a booster dose recommended every 2 years. The vaccine does not contain subunit B antitoxin; hence it does not require a buffer during administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\"><strong>CHOLERA ORAL VACCINES:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">&nbsp;Dukoral (WC-rBS): Monovalent, V cholera O1 plus Recombinant Toxin B subunit.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">2 doses (if age \u22656 years) and booster once/ 2 years</span></li><li><span style=\"font-size:18px;\">3 doses (if age b/w 2-5 years) and booster dose once per 6 months.</span></li></ul></li><li><span style=\"font-size:18px;\">&nbsp;Sanchol and mORCVAX: Bivalent, Serogroups O1 &amp; O139, No toxin B subunit, No buffer required. 2 liquid doses after the age of 1 year and booster after 2 years.</span></li><li><span style=\"font-size:18px;\">Euvichol: it is just like Sanchol. Bivalent with 2 doses.</span></li></ul>",
    "correct_choice_id": 229708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10185,
    "choices": [
      {
        "id": 40706,
        "text": "<p><span style=\"font-size:18px;\">Histogram</span></p>"
      },
      {
        "id": 40707,
        "text": "<p><span style=\"font-size:18px;\">Line diagram</span></p>"
      },
      {
        "id": 40708,
        "text": "<p><span style=\"font-size:18px;\">Component bar graph</span></p>"
      },
      {
        "id": 40709,
        "text": "<p><span style=\"font-size:18px;\">Multiple bar graphs</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>The following diagram depicts the fluctuation in population over the years spanning from 1983 to 1989 within a specific location. Which type of statistical diagram is being employed in this instance? </strong><i><strong>[NEET PG 2019]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/61.jpg\" alt=\"\" width=\"300\" height=\"297\"></strong></span></p>",
    "unique_key": "Q2308935",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175451,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Component bar graph</strong></span></p><p style=\"margin-left:-24px;\">&nbsp;</p><ul><li><span style=\"font-size:18px;\">The given image shows a component bar graph. It is used to represent data in which the total magnitude is divided into different subsets or components.</span></li><li><span style=\"font-size:18px;\">A bar chart or bar graph is used mainly for nominal or ordinal scale data. They can be simple, multiple or component bar graphs.</span></li><li><span style=\"font-size:18px;\">In a multiple bar chart, 2 or more sets of data are shown simultaneously.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. &nbsp;Histogram</strong> is used for continuous quantitative data presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/63.jpg\" alt=\"\" width=\"500\" height=\"286\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A bar chart can be distinguished from a histogram because the rectangles are</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">separated by the spaces. This indicates that the data forms discrete categories.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In a histogram, the rectangles are not separated by spaces as the data represented forms a continuous set instead of discrete groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Line Diagram</strong>: Is a better chart Used in depiction of TREND. There is no closed loop and no histogram in the background.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/64.jpg\" alt=\"\" width=\"500\" height=\"266\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Multiple Bar Graphs</strong>: Multiple bar graphs show two or more sets of data simultaneously with separate bars for each category side by side. This is different from a component bar graph, where each bar is divided into segments representing different components.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-125427_tdCdn02.jpg\" alt=\"\" width=\"500\" height=\"296\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A component bar graph is used to represent data where the total magnitude is divided into different subsets or components, effectively illustrating the proportion of each category within the total value.</span></p>",
    "correct_choice_id": 40708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "OlderNEETPG"
    ]
  },
  {
    "id": 57587,
    "choices": [
      {
        "id": 229717,
        "text": "<p><span style=\"font-size:18px;\">Only one of these</span></p>"
      },
      {
        "id": 229718,
        "text": "<p><span style=\"font-size:18px;\">Only two of these</span></p>"
      },
      {
        "id": 229719,
        "text": "<p><span style=\"font-size:18px;\">Only three of these</span></p>"
      },
      {
        "id": 229720,
        "text": "<p><span style=\"font-size:18px;\">All four are included</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>PQLI indicators include: </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\"><strong>Literacy rate</strong></span></li><li><span style=\"font-size:18px;\"><strong>Infant mortality rate</strong></span></li><li><span style=\"font-size:18px;\"><strong>Life expectancy at birth</strong></span></li><li><span style=\"font-size:18px;\"><strong>Income per capita</strong></span></li></ol>",
    "unique_key": "Q4419915",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175480,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Only two of these</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Physical Quality of Life Index (PQLI) is a measure used to assess the quality of life in different countries. It focuses on three main indicators: health, education, and living standards. Specifically, these indicators include:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>1. Literacy Rate</strong> (Education): This measures the education level within a population and is included in the PQLI.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>2. Infant Mortality Rate (IMR)</strong> (Living Standards): This measures the number of infants who die before reaching one year of age, reflecting living conditions and healthcare quality. It is included in the PQLI.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>3. Life Expectancy at Birth</strong>: This is not included in the PQLI; instead, PQLI considers life expectancy at age one.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>4. Income per Capita</strong>: This is not part of the PQLI; income measurements are used in the Human Development Index (HDI) but not in PQLI.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Thus, only the literacy rate and infant mortality rate are included in the PQLI.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">PQLI measures the quality of life based on literacy rate, infant mortality rate, and life expectancy at age one, excluding income and life expectancy at birth.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Remember \u2013 PQLI range \u2013 0 \u2013 100 (India - 65)</strong></span></p>",
    "correct_choice_id": 229718,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "RecentNEETPG"
    ]
  },
  {
    "id": 57601,
    "choices": [
      {
        "id": 229773,
        "text": "<p><span style=\"font-size:18px;\">Zika virus disease</span></p>"
      },
      {
        "id": 229774,
        "text": "<p><span style=\"font-size:18px;\">Dengue disease</span></p>"
      },
      {
        "id": 229775,
        "text": "<p><span style=\"font-size:18px;\">Yellow fever disease</span></p>"
      },
      {
        "id": 229776,
        "text": "<p><span style=\"font-size:18px;\">Nipah virus disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>A 35-year-old male patient presented to OPD with fever and neurological complications. He was having respiratory difficulty during the examination. Identify the disease transmitted through the life cycle shown in the image. </strong><i><strong>[NEET PG 2024]</strong></i></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174506.jpg\" alt=\"\" width=\"400\" height=\"274\"></strong></span></p>",
    "unique_key": "Q7445974",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175427,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Nipah virus disease</strong></span></p><p><br><span style=\"font-size:18px;\">The life cycle shown in the image involves Pteropus bats, also known as fruit bats or flying foxes, which are natural reservoirs for the Nipah virus. The transmission cycle depicted shows bats contaminating fruits or other food sources with their secretions, which can then be consumed by humans or other animals like pigs, leading to the spread of the virus. Nipah virus is known for causing severe respiratory illness and neurological symptoms, with <strong>a high fatality rate of around 50%</strong>. There is <strong>no vaccine</strong> for Nipah virus, and <strong>treatment is primarily supportive and symptomatic</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Incubation period \u2013 4-14 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Zika virus disease:</strong> Zika virus is primarily transmitted through mosquito bites and does not involve bats or fruit contamination in its transmission cycle. It primarily causes mild symptoms and is not associated with the severe respiratory and neurological symptoms described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Dengue disease:</strong> Dengue is transmitted by Aedes mosquitoes and does not involve bats or fruit contamination. It typically presents with fever, headache, and joint pain rather than severe neurological symptoms or respiratory difficulty.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Yellow fever disease:</strong> Yellow fever is also transmitted through mosquito bites, mainly the Aedes and Haemagogus species, and does not involve bats. It causes fever, jaundice, and bleeding but does not match the transmission cycle or clinical presentation described.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:18px;\">Nipah virus is transmitted through contact with Pteropus bats, contaminated food, or animals that have been exposed to the virus. It causes severe respiratory and neurological symptoms with a high fatality rate and no available vaccine.</span></p>",
    "correct_choice_id": 229776,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 44314,
    "choices": [
      {
        "id": 176907,
        "text": "<p><span style=\"font-size:12.0pt;\">Fowl</span></p>"
      },
      {
        "id": 176908,
        "text": "<p><span style=\"font-size:12.0pt;\">Man</span></p>"
      },
      {
        "id": 176909,
        "text": "<p><span style=\"font-size:12.0pt;\">Cattle</span></p>"
      },
      {
        "id": 176910,
        "text": "<p><span style=\"font-size:12.0pt;\">Fox</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the reservoir of leishmaniasis? (FMGE JANUARY 2024)</span></p>",
    "unique_key": "Q7014021",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175441,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Man</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The reservoir of visceral leishmaniasis, also known as kalazar or Indian kala-azar, is humans.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Visceral leishmaniasis (kalazar) is caused by the parasite Leishmania donovani.</span></li><li><span style=\"font-size:12.0pt;\">The vector responsible for transmitting the disease is the sandfly (Phlebotomus species).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/20/screenshot-2024-05-20-112958.JPG\" alt=\"\" width=\"300\" height=\"403\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The reservoir host of the disease is humans (man).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other 3 options are incorrect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For visceral leishmaniasis (kalazar or Indian kala-azar), the reservoir host is humans.</span></p>",
    "correct_choice_id": 176908,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10151,
    "choices": [
      {
        "id": 40570,
        "text": "<p><span style=\"font-size:18px;\">Secondary attack rate</span></p>"
      },
      {
        "id": 40571,
        "text": "<p><span style=\"font-size:18px;\">Case fatality rate</span></p>"
      },
      {
        "id": 40572,
        "text": "<p><span style=\"font-size:18px;\">Primary attack rate</span></p>"
      },
      {
        "id": 40573,
        "text": "<p><span style=\"font-size:18px;\">Tertiary attack rate</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>What is the term for the probability of infection occurring in susceptible individuals after they come into contact with an infectious person during the incubation period? </strong><i><strong>[NEET PG 2018]</strong></i></span></p>",
    "unique_key": "Q1373304",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175445,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Secondary attack rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Secondary Attack Rate (SAR): Is no. of exposed persons developing the disease within range of incubation period (IP), following exposure to the primary case</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">It is calculated by the following formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-094118.png\" alt=\"\" width=\"400\" height=\"49\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Primary case is excluded from both numerator &amp; denominator</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Secondary attack rate measures the communicability of the disease / Infectivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Case fatality rate:&nbsp;</strong>This rate measures the proportion of individuals diagnosed with a particular disease who die from that disease within a specific period. It is a measure of the severity of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Primary attack rate:&nbsp;</strong>This rate refers to the proportion of the population that becomes ill after being exposed to an infectious agent for the first time. It does not specifically account for subsequent spread among contacts.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Tertiary attack rate:&nbsp;</strong>This term is not commonly used in epidemiology. It would imply further transmission beyond secondary contacts, but this is not a standard measure</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The secondary attack rate is a crucial epidemiological measure for understanding the spread of infectious diseases among contacts of an initial case. It helps determine the infectivity and potential for outbreaks within a population.</span></p>",
    "correct_choice_id": 40570,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ]
  },
  {
    "id": 46433,
    "choices": [
      {
        "id": 185351,
        "text": "<p><span style=\"font-size:12.0pt;\">PHC</span></p>"
      },
      {
        "id": 185352,
        "text": "<p><span style=\"font-size:12.0pt;\">CHC</span></p>"
      },
      {
        "id": 185353,
        "text": "<p><span style=\"font-size:12.0pt;\">District hospital</span></p>"
      },
      {
        "id": 185354,
        "text": "<p><span style=\"font-size:12.0pt;\">Sub-centre</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Under the Urban health care system of India, the following health centre is not included: (FMGE JULY 2023)</span></p>",
    "unique_key": "Q5866431",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175462,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;District hospital</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">District hospitals, however, are not a part of the urban healthcare system's primary or secondary level facilities, hence they are not included.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Urban Health care system of India</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">There is a provision for creating <strong>urban health and wellness centres</strong>, which cater to a <strong>population of 15,000 to 20,000.</strong></span></li><li><span style=\"font-size:12.0pt;\">These centres are akin to primary health centres (PHCs) in rural areas. Additionally, Urban Primary Health Centres (UPHC), previously known as <strong>Urban Health Centres</strong>, serve a population of <strong>50,000</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Urban polyclinics</strong> are created for a <strong>population of 2.5 to 3 lakh</strong>.</span></li><li><span style=\"font-size:12.0pt;\">At the secondary level, <strong>Urban Community Health Centres (UCHC)</strong> are established for a <strong>population of 2.5 lakh in non-metro cities and 5 lakh in metro cities</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">District hospitals are not included in the urban healthcare system of India; instead, urban health facilities include Urban Health and Wellness Centres, Urban Primary Health Centres (UPHC), Urban Polyclinics, and Urban Community Health Centres (UCHC).</span></p>",
    "correct_choice_id": 185353,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE"
    ]
  },
  {
    "id": 10214,
    "choices": [
      {
        "id": 40822,
        "text": "<p><span style=\"font-size:18px;\">Hypochlorite ion</span></p>"
      },
      {
        "id": 40823,
        "text": "<p><span style=\"font-size:18px;\">Hydrochloric acid</span></p>"
      },
      {
        "id": 40824,
        "text": "<p><span style=\"font-size:18px;\">Hypochlorous acid</span></p>"
      },
      {
        "id": 40825,
        "text": "<p><span style=\"font-size:18px;\">Chloride ion</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Which compound among the options is predominantly responsible for the disinfectant quality to bleaching powder? </strong><i><strong>[NEET PG 2020]</strong></i></span></p>",
    "unique_key": "Q3386133",
    "question_audio": null,
    "question_video": null,
    "map_id": 34175464,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Hypochlorous acid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The primary reason for the disinfectant ability of bleaching powder stems from the activity of hypochlorous acid, which is responsible for its effectiveness. It surpasses hypochlorite ions in effectiveness by a factor of 70-80.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A.</strong>&nbsp;<strong>Hypochlorite Ion (OCl\u207b):</strong> While it does have disinfectant properties, it is much less effective compared to hypochlorous acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>Hydrochloric Acid (HCl):</strong> This is a byproduct of the reaction between chlorine and water but does not contribute significantly to the disinfectant quality.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D.</strong>&nbsp;<strong>Chloride Ion (Cl\u207b):</strong> This is also a byproduct of the disinfection process and does not play a direct role in the disinfectant action.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><u>Bleaching powder (CaOCl</u><sub><u>2</u></sub><u>)</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">2.5 gms of bleaching powder is sufficient to disinfect 1000L of water.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Mechanism of action:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">CHLORINE + IMPURITIES \u00e0 DESTRUCTION Add some additional Cl<sub>2</sub> [free residual Cl<sub>2</sub>]</span></li><li><span style=\"font-size:18px;\">Main disinfecting action of chlorine in water is due to HYPOCHLOROUS ACID [HOCL] [90% of disinfection] + Hypochlorite ions [10% of disinfection]</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">H<sub>2</sub>O + Cl \u2192 HCI + HOCI HOCI \u2192 H + OCI</span></p>",
    "correct_choice_id": 40824,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  }
];
        let quizName = 'Late Night Pyq:Pyt (Psm-8)';
        const quizFilename = 'late-night-pyq-pyt-psm-8-9cd6dbf0.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>